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A 3-DIMENSIONAL VASCULARIZED CARDIAC TISSUE MODEL USING 
CHITOSAN NANOFIBER SCAFFOLDS 
by  
Ali Hussain 
The development of an in vitro tissue model that can mimic the 3-dimenisonal (3-D) 
cellular architecture and mosaic of myocardial tissue holds great value for cardiac tissue 
engineering, modeling, and cardiovascular drug screening applications. The main 
objective of this project was to develop a 3-D vascularized cardiac tissue model in vitro 
for improved survival and function.  
The cellular mosaic of the myocardial tissue demands the intricate integration of 
an extracellular matrix-like scaffold, cellular constituents, and biological factors. The first 
aim of the research was to fabricate and characterize a biodegradable chitosan nanofiber 
scaffold that would resemble the extracellular matrix (ECM) physically and chemically. 
Chitosan, a natural polysaccharide that shares structural homology to the ECM 
glycosaminoglycans was processed into nanofibers via electrospinning to resemble the 
physical nano-architecture of the ECM. The second aim was to biologically modify the 
scaffold using a two step method: (1) Adsorption of fibronectin to improve cellular 
attachment and migration and (2) Induction of endothelial tubulogenesis to recreate the 
vascularized architecture of the myocardium. The third aim was to investigate the effect 
of co-culturing cardiomyocytes with fibroblasts on cardiomyocytes’ survival and 
contractility in the vascularized 3-D chitosan scaffold.  This was based on the fact that 




The chitosan scaffold was characterized for its physio-chemical properties, 
including in-vitro structural integrity and bio-degradability. The biomodification of the 
scaffold via fibronectin adsorption improved cellular attachment, verified by staining of 
actin (cytoskeletal protein) and vinculin (cell-adhesion protein). The endothelial cells 
formed a network of interconnected tubes and secreted GAGs that were immobilized onto 
the chitosan scaffold. The cellular studies showed that cardiomyocyte mono-cultures 
resulted in islands of isolated contractions and minimal gap junction expression. In 
addition, cardiomyocyte contractility was lost after four days in the mono-cultures. 
However, co-culturing the cardiomyocytes with the fibroblasts promoted tissue-like 
synchronous contractions that were sustained for over three weeks. Gap junction 
expression in cardiomyocytes-fibroblasts co-cultures was extensive and was expressed 
along the cardiomyocyte cell membranes.  
Finally, to create the cardiac tissue model, the vascularized chitosan nanofibers 
were impregnated with a co-culture system of cardiomyocytes and fibroblasts. Using 
real-time intracellular calcium ion staining, the cardiomyocytes were observed to have 
migrated through the 3-D chitosan scaffold and attained intercellular alignment to form 
cardiomyocyte tubules which is a characteristic of in vivo cardiomyocytes. The 
cardiomyocyte tubules were verified to contract in a synchronized and tissue-like 
rhythmic manner. These results highlight the immense importance of the vascular 
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2.1 Average Fiber Diameters of Pure Electrospun Chitosan Nanofibers 





























1.1 The main components of a tissue engineered construct…………… 
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1.2 Flowchart representations of the pathophysiological events that 
develop during ventricular remodeling. ECM: extracellular matrix; 
RAAS: rennin-angiotensin-aldosterone system; CO: cardiac 
output; SVR: system vascular resistance; LV: left ventricle; and 







1.3 Potential tissue engineering methods for the treatment of 
myocardial infarction. (1) Polymer restraints can be used to 
maintain the left ventricles geometry and slow ventricular 
remodeling. (2) In vitro tissue engineering utilizes biomaterial 
scaffolds impregnated with cells in vitro and then transferred to 
the epicardial infarcted region. (3) In situ tissue engineered 
involves the local injection of a biomaterial, or biomaterial + cells 










1.4 The structural homology of the (a through d) natural 




1.5 Graphical representation of a 3D biomaterial cellular scaffold 
portrays the signals that can be transferred to the cells via the 
physical architecture or biological components that ultimately 
control cell fate and functionality. The architectural components 
include but are not limited to the permeability, stiffness, 
degradability, and dimensionality of the structure. The biological 
components refer to proteins, growth factors or other 
bioresponsive molecules (molecules that elicit biological 
responses from cells) that can be incorporated within the scaffold 












2.1 A typical electrospinning setup for the fabrication of a non-woven 




2.2 The viscosity of chitosan solutions using two solvents, (black: 



















2.3 SEM images of vacuum dried electrospun pure chitosan prepared 
from 8% (w/v) chitosan dissolved in trifluoroacetic 
acid/methylene chloride (8:2) solution. (A) 5000 X original 
magnification (B) 50,000X original magnification. (C) Fiber 
diameter distribution of the chitosan nanofibers. Average diameter 







2.4 The stress-strain profile of electrospun pure chitosan nanofibers 
under uni-axial tensile stress applied using an INSTRON 





2.5 (A) Graphical representation of the widening of the electrospun 
chitosan fiber diameter distribution during 0, 1, 7, 14, 21, 28 days 
of PBS incubation. (B) SEM of electrospun chitosan fiber after 28 
days of PBS incubation showing the increased fiber diameter 







2.6 (A) Graphical representation of dry weight loss percentage of 
electrospun chitosan nanofibers during in vitro bio-degradation 
assay using lysozyme. (B) SEM of the electrospun chitosan 








2.7 FT-IR analysis of the unprocessed chitosan polymer powder, cast 
film from the electrospinning chitosan solution, and the 





2.8 (A) Differential Scanning Calorimetric analysis and (B) Thermal 
Gravitational Analysis of the unprocessed chitosan powder and the 




2.9 X-ray diffraction patterns of unprocessed chitosan powder, 
chitosan film and electrospun chitosan nanofibers………………... 
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3.1 Fibronectin adsorption on chitosan. (A) Relative fluorescence 
intensity of adsorbed fibronectin on chitosan coated tissue culture 
dishes at various fibronectin concentrations by 
immunofluorescence staining. (B and C) Light phase and 
immunofluorescence staining for anti-fibronectin of chitosan 





















3.2 Morphology, Vinculin (focal adhesion) expression, and 
cytoskeletal F-actin organization of (A and B) endothelial cells 
(EC) and (C and D) cardiomyocytes cultured on chitosan and 
chitosan-fibronectin coated tissue cultured dishes (day 2 cultures). 
Light phase contrast and immunoflourescence staining images for 
Vinculin (green), cytoskeletal F-actin (red), and nuclear DAPI 










3.3 (A and B) SEM micrographs of non-coated and fibronectin coated 
chitosan nanofibers seeded with endothelial cells after 1 day 
culture. 5,000X original magnification. (C and D) Live cell calcein 
AM stained endothelial cells cultured on non-coated and 









3.4 (A) Live cell calcein AM staining (B) Dead cell Ethidium 
homodimer staining and (C) Light phase image of 3T3-J2 
fibroblasts cultured on chitosan-fibronectin adsorbed nanofibers 
for 4 days. 200X original magnification. (D-F) SEM images of 
fibroblasts, cardiomyocytes, and endothelial cells cultured on 










3.5 (A) SEM micrograph of fibroblasts cells after 9 day culture in 
chitosan nanofibers showing the extension of pseudopods to attach 
to physically attach to the fibers, 5000X original magnification. 
(B)  SEM micrograph of fibrous extracellular matrix extruding 
from the cell surface to the chitosan nanofibers. (C) 
Immunofluorescent staining of cytoskeletal f-actin (red) and 
nuclear DAPI (blue) to illustrate fibroblasts day 9 cellular 










3.6 Light phase images of LSEC cultured on collagen gel and Matrigel 
at two cell densities. (A) collagen at 50 k/cm
2
 (B) Matrigel at 50 
k/cm
2
 (C) collagen at 125 k/cm
2
 (D) Matrigel at 125 k/cm
2
. All 
images were captured after 24 hours of incubation at 37°C and 







3.7 Calcein AM live cell staining of LSEC cultures in chitosan 
nanofiber mats (A) day 1 (B) day 7 (C) day 14 and (D) day 21. 












3.8 LSEC tube-like network structures in the chitosan nanofibers 
80k/cm
2
 at day 14 (A) Calcein AM live cell stained image 200X 
(B) Scanning electron micrograph 10000X and (C) Safranin-O 










4.2 Graphical representation of the diverse cellular milieu of the 
myocardium. The cells have unique and overlapping contributions 





4.3 Diagrammatic representation of the connexin 43/45 gap junctions 
between fibroblasts and cardiomyocytes that regulate the syncytial 





4.4 Graphical representation of the paracrine and autocrine signaling 




4.5 Morphology and phenotypic characteristics of primary neonatal 
cardiomyocytes cultured on 2-dimensional Chitosan-fibronectin 
films. (A,D) Cardiomyocyte monoculture, (B, E) Cardiomyocytes 
co-culture with fibroblasts, and (C, F) cardiomyocytes with 
endothelial cells after 7 days incubation at 37°C and 10% CO2. 
Cardiomyocytes were immunostained for α-sarcomeric actin (SA) 











4.6 Morphology and phenotypic characteristics of primary neonatal 
cardiomyocytes cultured in 3-dimensional chitosan electrospun 
nanofibrous matrices. (A,D) Cardiomyocyte monoculture, (B, E) 
Cardiomyocytes co-culture with fibroblasts, and (C, F) 
cardiomyocytes with endothelial cells after 19 days incubation at 
37°C and 10% CO2. Cardiomyocytes were immunostained for α-
sarcomeric actin (SA) and connecin-43 (Cx43) gap junction 










4.7 Pseudo-color time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 2D monoculture of neonatal 















4.8 Frequency of intracellular calcium ion flux in the 2D monoculture 




4.9 Pseudo-color time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 2D co-culture of neonatal 







4.10 Frequency of intracellular calcium ion flux in the 2D co-culture of 






4.11 Pseudo-color time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 3D co-culture of neonatal 







4.12 Frequency of intracellular calcium ion flux in the 3D co-culture of 






4.13 Pseudo-color intensity time frame images of intracellular calcium 
ion flow in 3D tri-culture system of endothelial cells, neonatal 







4.14 Frequency of intracellular calcium ion flux in the 3D tri-culture of 
endothelial cells, neonatal primary cardiomyocytes, and fibroblasts 





4.15 The transport of calcium ions in ventricular myocytes. The inset 
graph depicts the time course of a cardiomyocyte action potential, 
Ca ion transient concentration and cardiomyocyte contraction in a 
rabbit ventricular myocyte at 37°C. NCX: Na/Ca exchange; ATP: 















1.1 Tissue Engineering 
 
Tissue engineering was born out of the need to replace organs or tissues that become 
incompetent due to age, trauma, or pathologies. Some organs such as the heart and brain 
do not possess extensive regeneration capabilities following major trauma. Organ 
transplantation has been the main solution for complete organ failures. However, organ 
transplantation comes with a number of major drawbacks such as donor shortage, 
immuno-rejection and risk of transferring donor cancer stem cells. Other organ and tissue 
replacement approaches involve autografts (transplanted from the patient‟s own healthy 
tissue), allografts (transplanted from a genetically non-identical member of the same 
species), and biomaterial medical device implants. These tissue replacement methods 
have disadvantages which include donor site morbidity, poor integration, and 
immunologic reactions.  
Tissue engineering has emerged as an alternative option to organ transplantation 
and replacement since it presents the opportunity to provide “off the shelf” and 
immunologically safe tissue regenerative solutions that help the body heal itself. 
Advances in tissue engineering have accelerated due to interdisciplinary collaboration 
between researchers in biology, medicine, material science, and engineering. The 
advancement and maturity of tissue engineering as a field depends on the extent of this 
interdisciplinary integration, since understanding tissue-specific functionality and repair 




composition and architecture, physiological requirements, extracellular niche, and many 
other biological, physical, and chemical parameters. Figure 1.1 illustrates the key factors 









Figure 1.1 The main components of a tissue engineered construct. 
 
1.2 Myocardial Infarction and Cardiac Tissue Engineering 
Heart disease is a preeminent cause of death in the world, responsible for about 40% of 
human mortality. Annually in the United States, 550,000 new cases are diagnosed and 
about $33 billion is spent on dealing with heart failure [1].  There is a large variety of 
pathologies that cause heart failure such as ischemic heart disease which is sometimes 
accompanied with acute myocardial infarction, hypertension, and primary myocardial 
disease. Ischemic heart disease followed by an episode of acute myocardial infarction is 
the most frequent cause of left-sided cardiac failure [1].  
One of the major causes of end stage heart failure is myocardial infarction. When 
the blood vessels supplying the physiologically demanding myocardium tissue become 
Biomaterial Scaffold: 
Natural or synthetic polymers, 
ceramics, metals. 
Hydrogels, nanofibers, freeze 
dried sponges,  
Cellular Composition: 
Stem cells, co-culturing, feeder 
layers  
Signaling Biomolecules: 






occluded, the downstream tissue experiences ischemia. The metabolic strain on the 
myocardial tissue will lead to cardiomyocyte demise which is medically labeled as 
myocardial infarction. More importantly myocardial infarction leads to myocyte slippage. 
The term myocytes slippage refers to the sliding of bundles or singular myocytes along 
the longitudinal axis of the tissue lamina [2]. The necrosis of the cardiomyocytes caused 
by the ischemia activates multiple neurohormonal and inflammatory pathways, depicted 
in Figure 1.2, that lead to the degradation of the fibrillar collagen network connections 
that provide the structural integrity to the myocytes bundles. 
 
Figure 1.2 Flowchart representations of the pathophysiological events that develop 
during ventricular remodeling. ECM: extracellular matrix; RAAS: rennin-angiotensin-
aldosterone system; CO: cardiac output; SVR: system vascular resistance; LV: left 




  The replacement of the damaged myocardium with a non-contractile fibrous scar 
tissue compromises heart contractile efficiency. In addition, the collagenous extracellular 
matrix is weakened leading to a thin heart wall, ventricular dilation and remodeling. The 
damage to the heart wall is permanent because following extensive cell loss, the 
myocardium does not possess intrinsic regenerative capability [4]. Furthermore, the 
myocardium contains very limited and sparse number of cardiac stem cells making native 
regeneration a localized and ineffective solution for a large infracted region [5]. 
The ventricular remodeling that occurs following myocardial infarction is 
characterized by increase in cardiomyocyte cell volume: myocytes hypertrophy and the 
excess deposition of collagen fibers in the myocardial extracellular environment. These 
physiological and physical changes in the cellular and acellular components of the 
myocardium serve to compensate for the non-contractile scar tissue formed in the 
infarcted heart. However, this excessive and pathological secretion of ECM components, 
mainly collagen, leads to systolic and diastolic dysfunction of the ventricles since it 
affects cardiac conduction capabilities [6]. As a result, the remodeled heart undergoes 
hypertrophy and increased collagen secretion that eventually predisposes it to end stage 
of congestive heart failure.  
Currently, several medical treatment regiments are indicated to control the 
ventricle remodeling or slow the pace of progression to heart failure. Pharmacological 
therapeutics reduces the heart‟s work load via diuretics and nitrates. In addition, humoral 
factors can be blocked, via ACE inhibitors or B-blockers, since they are over activated in 
heart failure [7]. Interventional therapy, such as implanting pacing devices can be 
performed to control electrical/mechanical asynchrony. Nonetheless, pharmaceutics and 
5 
 
surgery fall short from preventing progression to end stage heart failure [8]. Ultimately, 
heart transplantation is the final option for end-stage heart failure. However, due to the 
scarcity of heart donors and the confines and complications linked with immune 
suppression and rejection researchers are turning towards cardiac tissue engineering to 
discover effective solutions to revive the distressed heart. 
Seminal studies published in the early 1990s depicted long-term survival and 
differentiated phenotype of transplanted skeletal myoblasts in the ventricular 
myocardium [9-11]. These studies paved the way for cardiac tissue engineering and shed 
light on the possibility of replacing the injured myocardium with healthy cells. Cell 
transplantation procedures into the injury site are dependent on the cell species and the 
transplantation method to provide optimal engraftment of the cells. Every cell in the body 
requires a niche which is characterized by unique physical, chemical, and biological 
parameters that supports its survival and induces optimal cellular functionality. It has 
been reported that more than 90% of the cells injected into the ventricular wall are lost 
since the cells do not undergo engraftment immediately when introduced into the native 
heart tissue [12].  
Hence, the goal of in vitro myocardial tissue engineering, as seen in Figure 1.3, is 
to create a physically, chemically, and biologically designed scaffold that the cells can 
adhere to and function on, until they engraft within the native tissue. The ex vivo 
generation of a 3D myocardial tissue employing cells, biomaterials, and bio-molecules 
provides a temporary niche for the cardiomyocytes to become functionally mature and 




Figure 1.3 Potential tissue engineering methods for the treatment of myocardial 
infarction. (1) Polymer restraints can be used to maintain the left ventricles geometry and 
slow ventricular remodeling. (2) In vitro tissue engineering utilizes biomaterial scaffolds 
impregnated with cells in vitro and then transferred to the epicardial infarcted region. (3) 
In situ tissue engineered involves the local injection of a biomaterial, or biomaterial + 
cells or only biological factors. [13]  
 
 
1.3 Current State of the Art 
The objective of cardiomyocyte-based engineered tissue constructs is to produce a 
contractile tissue-like patch that can be used to restore the contractility and pumping 
efficiency of the infracted region. Ideally, these constructs have to be clinically relevant 
in terms of thickness (~1.5cm for human myocardium), mechanical stiffness (10-20 kPa 





) consisting of aligned myofibers [14-17]. None of the cardiac constructs 
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currently generated have reproduced fully clinically relevant constructs in terms of 
thickness or functionality. The following are some promising examples of in vitro cardiac 
constructs that have been implanted in vivo. 
Zimmerman et al. fabricated a ring-shaped cardiac construct using neonatal 
cardiomyocytes seeded on collagen I gel mechanically conditioned using a bioreactor. 
The construct exhibited spontaneous contractions and was shown to improve cardiac 
performance after implantation [18, 19]. However, the construct was 1-4mm thick and 
histological integration (desmosomes and gap junctions) between the implant and the 
host tissue was not confirmed.  
Leor et al. developed cardiac grafts by culturing cardiomyocytes on freeze-dried 
alginate scaffolds and implanted them into the infracted myocardium. The observations 
demonstrated a significant increase in angiogenesis of the graft but no change in cardiac 
contractility [20]. Okano et al. produced cardiomyocyte cell sheets by culturing them on 
thermosensitive polymer poly (N-isopropylacrylamide). These polymers are hydrophobic 
and cell adhesive at 37°C; however, when the temperature is dropped to 32°C, they 
hydrate and become hydrophilic causing the cells to detach as a single cellular sheet [21]. 
These cellular sheets have been shown to electrically couple and pulse in a synchronized 
manner. In addition, four sheets were layered to form a pulsatile cardiac tissue grafts that 
was then implanted subcutaneously into rats and shown to survive three months in vivo 
[22]. Most of the developed cardiac constructs use only cardiomyocytes seeded on a 






In my opinion, the main requirements for a biomaterial are biological performance and 
biodegradability.  The author defines biological performance as the materials‟ ability to 
elicit the cells to perform the desired function without any adverse side-effects. An 
example of an adverse side-effect is inflammatory responses, the biomaterial must be a 
non-foreign body-reaction forming substance, i.e., its presence in the body should not 
trigger an immune response wherein macrophages start to fuse together forming foreign 
body giant cells that encapsulate the biomaterial and prevent it from performing its 
intended function [23].  Biodegradability defines the material‟s decomposition via natural 
in vivo processes. The degradation by products should be non-toxic and easily removed 
from the body.  
Typically, biomaterials can be divided into two broad categories: natural and 
synthetic materials. Both categories have with advantages and disadvantages. Proteins are 
great natural materials since they possess the ability to exhibit receptor-binding amino 
acid sequences to the cells. They are also susceptible to cell-mediated proteolytic 
biodegradation. However, they have complex purification procedures and present the risk 
of disease transmission [24]. On the other hand, biologically inert and non-biodegradable 
synthetic materials provide batch-to-batch uniformity and can have manufactured tailored 
properties.  
The choice and modification of the biomaterial is dependent on the intended 
application. For tissue engineering, each tissue or cell type will require certain chemical 
and physical requirements from the biomaterial to enable the optimum functioning of the 
engineered graft. The effect of the biomaterials on cellular function is a vital aspect in 
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ensuring that the cells can function when transplanted to the site of injury. For instance, 
nerve cells have been shown to exhibit significant enhancement in neurite extension 
when cultured on piezoelectric biomaterials [25, 26]. These piezoelectric biomaterials 
such as poled polyvinylidene fluoride contain transient surface charges that have been 
attributed to the improvement in neurite growth [27]. Similarly, skin regeneration is 
improved by the use of an upper silicone membrane which maintains a certain moisture 
level at the wound site, accelerating the healing process and induces skin re-growth [28]. 
1.4.1 Chitosan 
Chitosan is a copolymer consisting of D-glucosamine and N-acetyl-D-glucosamine 
monomers derived from natural chitin by basic deacetylation. Because of chitosan‟s 
solubility in acidic solutions, it is used in more applications compared to chitin [29].  
Recently chitosan‟s biodegradability, non-toxicity, wound-healing properties, 
biocompatibility, antimicrobial activity, and low immunogenicity have highlighted its 
potential in numerous industries ranging from waste-management, cosmetics, 
pharmaceutics, medicine and textiles [30-32]. Chitosan‟s use as a biomaterial is driven by 
its (1) economic cost (2) structural homology to the ECM GAGs as seen in Figure 1.4 (3) 
positive charge allowing it to interact with negatively charged GAGs and growth factors 
(4) anti-microbial properties and (5) derivation from chitin, the second most abundant 




Figure 1.4 The structural homology of the natural glucosaminoglycans (a through d) to 
chitosan (e) [34] 
 
In terms of tissue engineering applications, chitosan has been used in skin [35], 
bone [36], and neural [37]. To date, chitosan has not been used in cardiac tissue 
engineering as seen in Table 1.1 which is referenced from a 2010 published review on 














Fibrin glue [42] 
Collagen and Matrigel [43, 44] 
Synthetic materials 
Polyglycolic acid (PGA) [45, 46] 
Poly(glycerol sebacate) PGS [47] 
Poly(e-caprolactone-co-L-lactide) (PCLA) [48] 
Poly(N-isopropylacrylamide) (PIPAAm) [22] 
Polyurethanes (PU) [49] 
Poly(glycolide-co-lactide) (PLGA) [50] 
PGA-co-poly-4-hydroxybutyrate (PGA/P4HB) [51] 
 
1.4.2 Scaffolds 
Scaffolds provide a 3-dimensional physical structure where the cells can attach, migrate, 
generate their own extracellular matrix, and proliferate into a functional tissue according 
to the scaffold‟s shape. During the early 1980s, Bissell et al. published a groundbreaking 
report coining the term “dynamic reciprocity” to articulate the delicate interplay between 
the extracellular matrix‟s physical and chemical cues on the cell‟s cytoskeleton, nuclear 
matrix and ultimately gene expression [52]. Hence, the scaffold‟s design in terms of 
architecture and the biological performance is critical to the survival and optimum 
cellular functionality as seen in Figure 1.5. The scaffold also provides structural stability 
for the newly forming and developing tissue until it is capable of functioning in its native 




Figure 1.5 Graphical representation of a 3D biomaterial cellular scaffold portrays the 
signals that can be transferred to the cells via the physical architecture or biological 
components that ultimately control cell fate and functionality. The architectural 
components include but are not limited to the permeability, stiffness, degradability, and 
dimensionality of the structure. The biological components refer to proteins, growth 
factors or other bioresponsive molecules (molecules that elicit biological responses from 
cells) that can be incorporated within the scaffold to induce or activate certain molecular 
pathways. [53] 
    
The best scaffold for the cells is the natural extracellular matrix generated by the 
cells themselves. Thus it comes as no surprise the extensive attention given to replicating 
the architecture and biological conductance of the natural extracellular matrix. The 
natural extracellular matrix can be divided into two main categories: interstitial/stromal 
and basement membrane [54]. Each type is unique in its architecture and biological 
composition. The interstitial extracellular matrix provides the intercellular milieu, 
13 
 
however the basement membrane is a sheet-like basolateral substratum that delineates 
cellular structures. 
The architectural elements of the extracellular matrix include a network of fibrous 
protein components including collagen, fibrin, and elastin and a hydrogel matrix of 
glycosamino glycans such as hyaluronic acid, heparin sulfate, and keratin sulfate. Hence, 
the extracellular matrix can be visualized as a fiber reinforced hydrogel. The biological 
functionality of the extracellular matrix arises from its: 
1. Ability to sequester, store, and present soluble growth factors and regulatory 
molecules [55]. 
2. Availability of multidomain proteins such as fibronectin, laminin, vitronectin, and 
entactin. These proteins have numerous functions such as cell attachment, 
activation of developmental processes, and cell differentiation [56].  
3. Control of cell shape and cytoskeletal mechanics by changing the extracellular 
matrix stiffness [57].  
Combining the architectural and biological aspects of the cell-extracellular matrix 
interaction, it is evident that a coupling between the insoluble architectural ECM factors 
and the chemical and biological soluble ECM factors tightly control the cells fate, 
survival, migration, proliferation, and differentiation [58].Furthermore, each tissue‟s 
ECM will vary significantly in terms of composition, physical structure, and biological 
components according to the developmental, functional, and healing processes. It is 
important to realize the function of the malleability of the ECM in response to 
physiological needs. For example, during cardiogenesis, the acellular ECM is surrounded 
by endocardial and myocardial cell layers. The endothelial cells differentiate into 
primordial heart valves in response to an increase in ECM synthesis by the myocytes. 
The primitive mouse ECM has been shown to retain bone morphogenic proteins and 
other transforming growth factor-beta family of cytokines in an inactive form until 
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activation is triggered by ECM degradation which induces endothelial cell migration and 
the advancement of cardiac development [59]. On the other hand, an increase in synthesis 
by fibroblasts during cardiac injury causes excess collagen deposition and fibrosis [60].   
Hence, since the optimal scaffold for the cells is their native extracellular matrix; the 
engineered scaffold should interact with the natural extracellular matrix and enable the 
presentation of the ECM to the cells until complete engraftment in the host tissue.  
 
 
1.5 Cell Sourcing 
The biggest hurdle in cardiac tissue engineering is the quest for an appropriate cell source. 
The heart tissue is one of the most densely populated tissues, 40 million cardiomyocytes 
per gram of native myocardium [61]. Hence, the primary cells currently used in cardiac 
tissue engineering research are proof-of-concept substitutes. Cardiac tissue engineering 
cannot be translated into a clinically relevant therapy until an appropriate cell source has 
been found.  
The following options are some of the cell sources currently being investigated 
for cardiac regenerative therapies: 
1. Adult stem cells found in the bone marrow [62], peripheral blood [63], umbilical 
cord [64] and adipose tissue [65] have been observed to give rise to 
cardiomyocytes.  
2. Resident progenitor cells in the heart have the potential to differentiate into 
functional cardiomyocytes [66]. 
3. Alternative to adult stem cells, embryonic stem cells have been shown to 
spontaneously differentiate into cardiomyocytes [67], however the major 
drawback of embryonic stem cells is their potential to form tumors and difficulty 
to differentiate into pure cell lineages. 
The cell sourcing issue in cardiac tissue engineering remains to be the main 
determining factor on whether adult cardiac regeneration ever becomes a reality. Table 
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1.2 provides up to date cell sources that are currently being investigated to populate the 
injured heart. 
Table 1.2 Review of the Cell Sources Used in the Treatment of Myocardial Diseases  
Cell source Differentiation potential Current usage 
Skeletal myoblasts Terminal differentiation Repopulate scar tissue and 





Repopulate damaged myocardium 
Bone marrow cells Cardiomyocytes, vascular 
endothelium 
Repopulate damaged myocardium 
Endothelial progenitor 
cells 
Vascular endothelium Neo-vascularization to prevent 
myocardium apoptosis and LV 
remodeling 
Resident cardiac stem 
cells 
Cardiomyocytes Improve cardiovascular function 




















This research‟s overall aim is to engineer a myocardial tissue model construct that can 
mimic the 3-dimensional cellular architecture and mosaic of myocardial tissue. This 
cardiac tissue model can potentially be used in myocardial tissue regeneration or utilized 
as a platform technology for diagnostics, drug screening or therapeutics. The motivation 
is to attain extended cardiomyocyte viability and functionality in a 3-dimensional in 
vitro tissue model. This study hypothesizes that co-culturing primary cardiomyocytes 
with fibroblasts will improve cardiomyocyte longevity and functionality in vitro. Specific 
aims are listed below: 
1. The fabrication and characterization of chitosan nanofibrous scaffolds.  
2. Biomodification of the chitosan nanofibrous scaffolds to create a vascularized 
cellular niche. 
3. Improve cardiomyocyte longevity and functionality by co-culturing with 
fibroblasts. Impregnate the biomodified chitosan scaffolds with cardiomyocytes 
and fibroblasts co-culture and assess cardiomyocyte functionality.  
The uniqueness of the approach taken in this research is the use of all three of the 
main cell types present in the myocardium: cardiomyocytes, fibroblasts, and endothelial 
cells to recreate the in vivo myocardial cellular niche. Moreover, the three cells types are 
not simply seeded on the scaffold, rather the scaffold will first be vascularized using 
endothelial cells to recreate the rich vasculature bed that perfuses the myocardial tissue 
and then the vascularized scaffold will be impregnated with a co-culture of 





The novelties in this research are: 
1. This is the first report to investigate the potential of chitosan nanofibers in the 
field of cardiac tissue regeneration. 
2. This is the first report to induce vascularization on chitosan nanofibers. 
























FABRICATION AND CHARACTERIZATION                                                         
OF ELECTROSPUN CHITOSAN SCAFFOLDS 
 
 
2.1 Introduction to Electrospinning Chitosan 
 
Electrospinning is a polymer processing technique that generates fibers in the micro- to 
nano-dimensions. Nanofiber scaffolds have are widely used in tissue engineering because 
of their architectural resemblance to the natural extra-cellular matrix. Furthermore, 
electrospinning provides a quick cost-effective and relatively simple processing method 
to produce ultra-fine nanofibers into non-woven oriented or non-oriented matrices. A 
typical electrospinning setup includes a metal needle connected to a syringe, a pump flow 
rate controller, a DC voltage supply and a grounded plate collector as shown in Figure 
2.1 
Figure 2.1 A typical electrospinning setup for the fabrication of a non-woven randomly 
oriented fiber matrix.  
 
The theory behind the electrospinning process is that fiber formation occurs when 
the electrostatic forces created between the metal needle and the grounded collector plate 
has overcome the surface tension of the polymer solution. As the intensity of the 
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electrostatic forces increase, the polymer solution at the tip of the needle will elongate to 
form a Taylor cone. When the electrostatic forces overcomes the surface tension, the 
polymer solution gets drawn out as a taylor cone from which a linear region extends and 
undergoes a whipping process wherein the solvent evaporates very quickly depositing 
nano- to micro-scale fibers on the metal collector.  There are many factors that affect the 
formation of electrospun fibers: (1) Solution properties: molecular weight or 
concentration which affects viscosity, electrical conductivity, polarity and surface tension 
of solution. (2) Electrospinning chamber properties: Voltage supply intensity, 
electrospinning distance, solution flow rate, humidity, and temperature [68].    
The first published reports on electrospinning of pure chitin and chitosan were 
performed by Min et al. and Ohkawa et al. respectively in 2004 [69, 70]. Chitosan 
becomes water-soluble in acidic pH <6 by the protonation of the amine on the 
glucosamine group; this cationic nature poses a major challenge in electrospinning. Due 
to chitosan‟s polyelectrolyte behavior, hydrophilic nature, and water retaining properties; 
chitosan has the spontaneous capability to form gels in acidic pH which increases its 
viscosity and hinders the electrospinning process [71]. To overcome this challenge, high 
concentrations (80% to 100% v/v) of acids are usually used to electrospin chitosan 
ranging from moderately weak acids such as acetic acid to trifluoroacetic acid [69, 72, 
73]. 
This section of the research focused on the fabrication of the chitosan nanofibers 






2.2.1 Rheological Measurements of Chitosan Electrospinning Solution 
Commercially available medium molecular weight chitosan, purchased from Sigma-
Aldrich (448877-250G, Batch 07918TE) was dissolved at 8% (w/v) in 100% 
trifluoroacetic acid (TFA) (Fisher, O4901-500) by stirring for 15 hours at 45C. 
Methylene chloride (MeCl) (Fisher, D143-1) was added drop wise into the chitosan 
solution, while stirring, to the final (v/v) ratio of TFA: MeCl, 80:20. The viscosity of the 
chitosan electrospinning solution was measured using Rheometric Scientific (T.A. 
Instruments) Stress Rheometer SR 200 25mm PPS parallel plate at room temperature 
(25C - 30°C). The viscosity measurements were performed at various time points after 
initial mixing of the chitosan in the TFA (2, 15, 24 hours and 7 days).  
2.2.2 Chitosan Nanofibers Fabrication and Diameter Characterization 
The electrospinning apparatus used to generate the chitosan nanofibers included a syringe 
pump to pump the chitosan solution through an 18 gauge, 1 inch long metal needle at 3-
4ml/hour. A high voltage power supply of 25-30kV was attached to the needle and a 
grounded aluminum collector plate was positioned 25-30cm from the tip of the needle. 
The chitosan solution was placed in the syringe and electrospun at room temperature 
(25C to 30°C) and relative humidity of (20-30%). The chitosan nanofibers were placed 
under vacuum for 24 hours to remove the remaining solvent from the nanofibers. The 
fiber diameter distribution was determined using scanning electron microscopy (SEM) 
using a LEO 1530 Gemini microscope. The chitosan nanofibers were carbon sputter-
coated and examined by the SEM. Diameters of 195 fibers, 65 fibers from three 
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electrospun samples were measured. Sigma Scan Pro software was used to analyze the 
average fiber diameter.  
2.2.3 Mechanical Tensile Testing 
The Young‟s modulus and ultimate tensile strength were determined using an Instron 
uniaxial tensile testing equipment model 3343. The chitosan nanofiber matrices were 
prepared into rectangular strips (60x20mm). The relative humidity was 20-30%, gauge 
was set to 20mm and cross head speed of 10mm/min was used. All the strips were tested 
until complete rupture with a 100N load cell at room temperature (25-30°C).  
2.2.4 Fiber Swelling Assay 
The chitosan nanofiber mats were prepared into squares (20x20x0.15 mm3) and 
neutralized in a basic solution composed of 15N ammonium hydroxide and 100% ethanol 
(1:1 v/v) for 30 minutes. The nanofibers were then washed with deionized water three 
times, each time for 10 minutes. The nanofibers were placed in phosphate buffer solution, 
PBS; pH 7.2 and incubated at 37°C and 10% CO2. The PBS solution was changed every 
3 days. At certain time points (days 1, 7, 14, 21, 28) the nanofibers‟ diameter distribution 
was analyzed by SEM. The fiber diameters were quantified using Nikon Imaging 
Solutions (NIS)-elements basic research software (v.3-448). Three chitosan sample 
duplicates was used for each time point and a total of ~190 measurements were used to 
analyze the diameters. 
2.2.5 In Vitro Lysozyme Degradation Assay 
The chitosan nanofiber matrices were prepared into squares (20x20x0.15 mm3) and 
neutralized as mentioned above. The degradation of the chitosan nanofibers was assessed 
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by incubating them in egg-white lysozyme (MP Biomedicals LLC, CAT#100834) 
dissolved at 4mg/ml in PBS, pH 7.2, at 37°C and 10% CO2. At specific time intervals 
(days 7, 14, 21, 28) the matrices were removed from the lysozyme solution, washed with 
water, vacuum dried for 24 hours, and weighed. The degradation profile was illustrated 
using the weight loss percentage of the dried sample before and after degradation. 
2.2.6 Fourier Transform Infrared Spectroscopy 
Fourier transform infrared (FTIR) analysis was done using the Perkin Elmer FTIR-ATR 
100 series. The spectra were analyzed in the 400-2000cm-1 range with a resolution of 
4cm
-1
 and 30 scan repeats. Unprocessed chitosan powder, film cast from the 
electrospinning solution and electrospun nanofibers were analyzed. The chitosan films 
were cast by pouring 2ml of the chitosan electrospinning solution in an uncoated p35 
Petri dish and allowed to air dry in the chemical hood for over 48 hours. 
2.2.7 Thermal Analysis via DSC and TGA 
Thermogravimetric analysis (TGA, TA instruments model Q50, New Castle, DE) was 
performed in an inert atmosphere (dry nitrogen, flow rate 40ml/min), 10°C/min heating 
rate and maximum temperature of 300°C. Differential scanning calorimetry (DSC, TA 
instruments Q100, New Castle, DE) was performed in sequential double scans on each 
sample. The first scan was to remove the water in the sample which was followed 
immediately by the second scan.  
2.2.8 Molecular Organization Analysis via XRD 
Chitosan powder, cast film and electrospun nanofibers were analyzed by X-ray 
diffraction (XRD) using an X‟pert Pro Diffractometer (PW3050/60, Philips, Netherlands). 
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Monochromatized Cu K (1.54056A) X-ray source was used to irradiate the samples with 
a step size (2-theta) of 0.05°, scan step time of 1.0 sec and 2-theta range of 0-60°. The 
























2.3.1 Fiber Fabrication and Diameter 
At 2hrs after mixing 8% (w/v) chitosan in 100% TFA, the viscosity of the solution was 
12,700cP (Figure 2.2). The addition of the organic solvent MeCl to the solution caused 
the viscosity to dramatically drop to 1,400cP. It was observed that the viscosity of the 
electrospinning solution decreased as time progressed. Attempts at electrospinning the 
solution at 2hrs failed because the viscosity was too high for the solution to be smoothly 
pumped out of the needle.  
 
Figure 2.2 The viscosity of chitosan solutions using two solvents, (black: TFA, red: TFA 
and Methylene Chloride) post initial mixing. Graph insert is a close-up of the 2-24hrs. 
 
The optimized viscosity of the electrospinning solution that enabled the 
generation of smooth bead free fibers from chitosan was around 300 cP; this was 
achieved after 12-15 hours of stirring. Beyond this stirring window, the solution is not 
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viscous enough and electrospinning attempts led to the formation of droplets onto the 
metal collector. The optimized chitosan fiber matrices had an average fiber diameter of 
188±59nm and mat thickness ~150-200µm (Figure 2.3).  
 
 
Figure 2.3 SEM images of vacuum dried electrospun pure chitosan prepared from 8% 
(w/v) chitosan dissolved in trifluoroacetic acid/methylene chloride (8:2) solution. (A) 
5000 X original magnification (B) 50,000X original magnification. (C) Fiber diameter 




2.3.2 Instron Tensile Testing 
The uniaxial tensile properties of the chitosan nanofiber matrices were examined using an 
Instron. The stress-strain profile, seen in Figure 2.4, of the matrices resulted in an 
evolving stress-strain modulus. During the initial phase of the tensile loading, the elastic 
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modulus was 20.4MPa ± 5. Following further tensile loading onto the matrices, the 
stress-strain modulus increased significantly to 62.3MPa ± 5. The matrices ruptured at an 
ultimate tensile strength of 2.20 ± 0.37.  
 
Figure 2.4 The stress-strain profile of electrospun pure chitosan nanofibers under uni-
axial tensile stress applied using an INSTRON apparatus at 25°C.  
 
2.3.3 Fiber Morphological Stability  
The structural stability of the fibers was monitored during PBS incubation over 28 days. 
The freshly formed fibers (0 day incubation) displayed an average diameter of 188±59nm. 
Table 2,1, demonstrates that the increase in fiber average diameter and the diameter 
distribution range.   
Table 2.1 Average Fiber Diameters of the Pure Electrospun Chitosan Nanofibers 














The widening of the diameter distribution range suggests the presence of a range 
of swelling properties within the electrospun chitosan fibers. Hence, some fibers swell 
faster than others, as seen in Figure 2.5 which shows the distribution electrospun chitosan 
fiber diameters at several time intervals up to 28 days of PBS incubation. 
 
Figure 2.5 (A) Graphical representation of the widening of the electrospun chitosan fiber 
diameter distribution during 0, 1, 7, 14, 21, 28 days of PBS incubation. (B) SEM of 
electrospun chitosan fiber after 28 days of PBS incubation showing the increased fiber 
diameter distribution, 20, 000X original magnification. (50 measurements were 
performed from 3 replicate samples for each time period). 
 
2.3.4 Fiber In Vitro Degradation Assay  
The degradation study demonstrated significant changes in the rate of degradation with 
time. The chitosan fiber matrices showed the highest rate of degradation during the first 7 
days by displaying 30% dry weight loss. The matrices lost a further 13% dry weight 
during the following 21 days. The degradation profile shown using percent weight loss in 
Figure 2.5A demonstrates that the degradation rate is initially rapid followed by a slow 
degradation phase. The SEM micrographs (Figure 2.6B) of the chitosan matrices treated 
with lysozyme for 28 days depict that some of the fibers have maintained their smooth 




Figure 2.6 (A) Graphical representation of dry weight loss percentage of electrospun 
chitosan nanofibers during in vitro bio-degradation assay using lysozyme. (Blue: no 
lysozyme, red: with lysozyme) (B) SEM of the electrospun chitosan nanofibers after 28 
days incubation in lysozyme solution, 20,000X original magnification. 
 
2.3.5 Fourier Transform Infrared Spectroscopy 
The FTIR spectra of the chitosan film and electrospun fibers show the presence of  CH 
and CH2 peaks at 719-793 cm
-1
 and NH amine peak at 834cm
-1 
which are absent from the 
unprocessed chitosan powder spectra (Figure 2.7). The NH amide band was shifted 
downward from 1560-1553 cm
-1
 in the powder to 1525-1515cm
-1
 in the electrospun 








Figure 2.7 FT-IR analysis of the unprocessed (a) chitosan polymer powder, (b) cast film 
from the electrospinning chitosan solution, and the (c) electrospun chitosan nanofibers. 
 
 
2.3.6 Thermal Analysis 
 
Changes in heat flow in the sample and degradation temperatures were studied using 
DSC and TGA. The unprocessed chitosan powder and the electrospun chitosan fibers 
were compared. DSC profiles demonstrated broad endothermic events with peak maxima 
at 90°C for the electrospun chitosan fibers and 140°C for the chitosan powder during the 
first scan. The second DSC scan illustrated a change in heat flow at 120°C, and a broad 
endothermic event at 230°C followed by another event at 250°C. The chitosan powder‟s 
second DSC profile demonstrated a change in heat capacity at 200°C and an endothermic 




















TGA showed an initial weight loss that plateaus in both the electrospun chitosan 
fibers and powder. Further weight loss of the electrospun chitosan fibers started at a 




Figure 2.8 (A) Differential Scanning Calorimetric analysis and (B) Thermal 
Gravitational Analysis of the unprocessed chitosan powder and the electrospun chitosan 
nanofibers. 
 
2.3.7 X-ray Diffraction 
As depicted in Figure 2.9, the unprocessed chitosan powder had two broad peaks at 2-
theta = 10.2° and 19.9°, in addition to a broad background halo. The cast film from the 
fibers 









chitosan electrospinning solution resulted in one broad peak at 2-theta= 19.9°. The 
electrospun chitosan fiber XRD pattern resulted in the lowest intensity peak at 2-theta = 
19.9, two very sharp and intense peaks at 2-theta = 38.3° and 44.5° and the lowest 
amount of background halo. 
 
Figure 2.9 X-ray diffraction patterns of unprocessed chitosan powder, chitosan film and 
electrospun chitosan nanofibers.  
 
 
2.4  Discussion 
The goal of this section of the research was the fabrication and characterization of the 
physical, chemical, and thermal properties of electrospun chitosan.  
Electrospinning is a complex process affected by many parameters including the 
nature of the solvent‟s volatility and polarity, polymer concentration and molecular 
weight, surface tension, pump flow rate, voltage applied, electrospinning distance, 
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temperature, and humidity.  The viscosity of the electrospinning solution is vital in 
forming bead-free continuous fibers because very low viscosities imply that the solution 
is materially deficient to produce a continuous fiber. Solutions with very high viscosities 
would clog the metal needle and prevent the continuous flow of the polymer solution. 
The polymer solution‟s viscosity is influenced by the intermolecular interactions between 
the polymeric chains. Chitosan‟s high viscosity is caused by the strong and numerous 3-
dimensional networks of hydrogen bonds between the amine and hydroxyl groups [74, 
75]. TFA is used to dissolve chitosan because it forms amine salts with chitosan‟s C2-
amine groups [76]. The addition of the organic solvent methylene chloride causes a 
significant drop in the viscosity. This can be attributed to the disruption of the hydrogen 
bond network allowing the mobilization of the polymer chains under the influence of the 
electrical field.  
The reduced viscosity allows the chitosan solution to flow continuously out of the 
capillary tip enabling the formation of continuous bead free fibers.  The continuous drop 
in viscosity of the chitosan-TFA solution is attributed to the acid hydrolysis of the 
chitosan which is accompanied by the solution changing color from yellow to dark brown. 
This is due to the release of free glucoasmines which causes browning of the solution 
[77] . The acid hydrolysis of chitosan decreases the molecular weight, which in turn 
decreases the density of polymer entanglements present in the solution. These polymer 
entanglements are necessary for holding the polymer chains together to form a coherent 
fiber. As a result, with increase polymer degradation, the solution‟s spinnability decreases 
preventing the formation of a continuous fiber. Hence in electrospinning of chitosan form 
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an acidic solvent there exists a time period (12 to 15 hours in our study) prior and beyond 
which chitosan could not be electrospun.  
The random orientation of the electrospun chitosan nanofibers leads to the 
deposition of fiber entanglements within the matrix. These entanglements get engaged 
when the fiber matrix experiences tensile stress giving rise to a characteristic stress-strain 
modulus behavior. In Figure 2.4, the Young‟s modulus of the chitosan nanofibrous 
matrix increased as the stress applied increased. The increase in the modulus can be 
explained by the increase in the number of fiber entanglements engaged as more and 
more fibers are being pulled on.  Ultimately, the chitosan nanofibers rupture causing the 
entanglements to fail. 
Due to chitosan‟s high hydrophilicity and likelihood to form hydrogels, the 
structural integrity of the chitosan nanofibers was investigated in PBS for 28 days. 
Hydrophilicity is a vital feature of chitosan‟s appeal as a biomaterial as it enhances the 
production of the extracellular matrix and enhances homeostasis of wounds by 
accelerating blood clotting [78]. The incubation of the chitosan nanofibers in PBS 
resulted in swelling of some of the fibers while maintaining the cylindrical fibrous 
morphology. Some fibers swelled at a rapid rate, while others swelled at a slower pace or 
not at all. The variety in swelling behavior of the chitosan nanofibers can be explained by 
the differences between the chitosan inter-molecular hydrogen bonds. The fibers that 
exhibit inter-sheet hydrogen bonding prevent the chitosan from swelling and retaining 
water. While the fibers in which the inter-sheet hydrogen bonding is absent will swell and 
retain water [31].  
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Chitosan can be degraded by a variety of enzymes in vitro such as chitinase, 
chitosanase, lysozyme, collagenase and pectinase [79-81]. In vivo, lysozyme attacks 
chitosan‟s acetylated residues and hydrolyze its glycosidic bonds. Lysozyme is released 
from phagocytic cells such as macrophages and neutrophils [82]. The degradation by-
product of chitosan are aminosugars which are non-toxic, non-immunogenic, and 
completely absorbed by the body through glycosaminoglycans and glycoprotein 
metabolic pathways or excreted [83]. Figure 2.6 A show that the fibers undergo an initial 
phase of rapid degration followed by a phase of slower degradation. SEM micrographs 
shown in Figure 2.6 B, depict that some fibers have completely lost their cylindrical 
morphology and transformed into a film like structure, while others have maintained their 
fibrous structure.  The bi-phasic degradation model of the electrospun chitosan can be 
explained using the fiber swelling, XRD, and FTIR data. Correlating the degradation and 
swelling test results, it can be suggested that the fibers that exhibit rapid swelling also 
exhibit faster degradation rates.  
FTIR spectra of the electrospun chitosan nanofibers show bond vibration peaks of 
the amine and alkane groups that were absent in the unprocessed chitosan powder. This 
suggests that the 3-dimensional hydrogen bond network that immobilized these groups in 
the chitosan powder was disrupted during electrospinning. In addition, the electrospun 
chitosan‟s amide bands have shifted to higher frequencies compared to the chitosan 
powder indicating that the polymer chains have changed their physical organization 
compared to the powder [84].  
DSC results showed that the electrospun chitosan nanofibers have a change in 
heat flow at a lower temperature compared to the unprocessed chitosan powder. This 
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implies that the chitosan polymer chains in the unprocessed powder are physically 
organized in a different manner compared to the electrospun chitosan nanofibers. The 
thermal degradation behavior of chitosan is complex as it consists of dehydration, 
deacetyaltion and chain scission. The unprocessed chitosan powder started thermal 
degradation at a higher temperature compared to the electrospun chitosan fibers. This can 
be attributed to the fact that the electrospun chitosan fibers which were prepared from the 
TFA containing solution have undergone some degradation. During the electrospinning 
process, the acid hydrolysis of the chitosan chains and the remaining acidic solvent 
within the fibers will catalyze the degradation of the chitosan nanofibers as compared to 
the chitosan powder, as seen in Figure 2.8.  
The XRD data, Figure 2.9, supports the FTIR data as it indicates a more ordered 
molecular organization in the electrospun nanofibers as compared to the unprocessed 
chitosan powder. There are six polymorphs that have been proposed for chitosan: tendon, 
annealed, 1-2, L-2, form I and form II [85].The two peaks with lattice angles of 10.2° and 
19.9° are attributed to the equatorial (100) and (020) reflections seen in the „L-2‟ chitosan 
polymorph [86]. The L-2 organization of chitosan chains is significantly disrupted in the 
electrospun chitosan nanofibers because of the high speed elongational flow and rapid 
vitrification that occurred during electrospinning.  Electrospinning altered the molecular 
arrangement of the chitosan polymer chains and organized them with two uniform d-
spacings.  However, some of the L-2 morphology still remains within the electrospun 
samples. This diversity in molecular organization within the chitosan nanofibers might 







Pure electrospun chitosan nanofibers were fabricated and analytically characterized. The 
electrospinning of pure chitosan fibers was successfully reproduced by optimizing the 
stirring time of the chitosan in the TFA solution, which is correlated to the viscosity of 
the solution. The characterization results suggest that electrospinning of chitosan alters its 
molecular organization in a manner that produces two main types of polymer 
confirmations One type of polymer confirmation allows fiber swelling and rapid 
degradation by lysozyme. However, the other polymer confirmation swells and degrades 
at a much slower rate. Based on these observations, electrospinning of chitosan affects its 

















CHITOSAN BIOLOGICAL PERFORMANCE AND VASCUALRIZATION 
 
3.1 Introduction 
Many cellular processes, including the differentiation, proliferation, and survival, of 
adhesion dependent cells are affected by their attachment to the extracellular matrix. The 
adhesion and interaction of cells to their surrounding is mediated by a variety of 
transmembrane receptors, integrin being one of the most heavily studied and understood 
adhesion receptor. Integrins not only attach the cells to the extracellular matrix but they 
also act as a signal relay center where extracellular mechanical cues are internalized via 
interaction with cytoskeleton actin microfilaments and intermediate filaments [87]. 
However, these transmembrane integrin adhesion links also serve as a signaling pathway 
cluster where focal adhesion enters activate various signaling molecules including FAK, 
Src, and paxillin [88].    
Unique amino acid sequences, for example arginine-glycine-aspartic acid (RGD), 
present in the extracellular matrix mosaic of proteins provide the binding site for 
integrins. Hence, the integrin-mediated adhesion of cells onto biomaterials is dependent 
on the ability of the extracellular matrix proteins to adsorb and adequately present these 
amino acid binding sites to the cells. The biomaterial surface characteristics that affect 
protein adsorption include hydrophilicity/hydrophobicity, chemistry, surface charge and 
charge density, texture, crystallinity, and rigidity [89-92].  There are numerous 
techniques to improve the cytocompatibility of biomaterial surfaces including adsorption, 
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blending and crosslinking of proteins; however the main objective of those techniques is 
to present extracellular matrix motifs to the cells to enhance integrin binding.  
One of the most interesting biomaterial induced cell processes is the 
tubulogenesis of endothelial cells on Matrigel. This biomaterial induced phenomenon is 
the result of culturing endothelial cells on a gel material that consists of harvested rat 
chondrosarcoma extracellular matrix [93]. Matrigel contains many extracellular matrix 
proteins such as laminin-1, collagen IV and peptides C16 and A13 which are known to be 
proangiogenic signals [94]. However, it is unlikely that Matrigel will ever reach the 
patient‟s bedside since it is very costly and tumor derived.  
As a matter of fact, a major challenge in the engineering of any tissue, especially 
myocardial tissue, is the incapability of providing sufficient blood supply immediately 
post implantation. Engineering grafts for thick complex tissues such as cardiac tissue 
require adequate vasculature to sustain physiological requirements since the diffusion 
limit for oxygen is 100-200 m [95]. This challenge is intensified when engineering a 
physiological demanding tissue such as the myocardium. The native myocardial tissue is 
supplied by rich vasculature which is necessary to quench the immense demand for 
oxygen and nutrients required for its continuous vigorous contractile activity.  
In addition to serving as conduits for blood supply, endothelial cells are vital for 
promoting cardiomyocyte survival and function [96]. Neureglin secreted by endothelial 
cells affect cardiomyocyte survival, proliferation and hypertrophic growth through the 
phosphatidylinositol-3-kinase-AKt pathway [97-99]. Furthermore, cardiac endothelial 
cells influence cardiomyocyte contractility by the secretion of numerous modulators, 
such as nitric oxide which affects cardiomyocyte inotropism [100], endothelin causes 
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cardiomyocyte constriction [101] and platelet derived growth factor  (PDGF) affect 
cardiomyocyte development [102]. 
Several approaches have been investigated to vascularize cardiac grafts. Capsi et 
al. seeded human Embryonic Stem Cell derived endothelial cells (hESC-EC) or Human 
Umbilical Vein EC (HUVEC) on PLLA/PLGA porous scaffolds along with embryonic 
fibroblasts and were able to depict some vascularization [97].  Radisic et al. covalently 
immobilized angiogenic factors VEGF and angiopoietin-1 onto collagen sponges 
resulting in an increase in infiltration of murine embryonic heart endothelium cells into 
the scaffold and an elongated cellular morphology [103]. Okano et al. were able to show 
in growth of vasculature from HUVEC sheets into fibroblast sheets that were stacked on 
top of each other [104]. Dvir et al. were successful in showing that maturing their cardiac 
Matrigel incorporated constructs on a blood rich membrane, rat omentum, enabled the 
formation of functional blood vessel networks [105]. Matrigel is a biological mixture of 
the basement membrane extracted from rat chondrosarcoma ECM, which makes it 
unfavorable for patient use [93]. While these vascularization attempts have led to limited 
success, the goal of engineering a favorable technique to generate 3-D vasculature 
networks within scaffolds remains elusive.   
This section of the research focused on the improvement of chitosan‟s 
cytocompatibility by adsorbing fibronectin on its surfaces. In addition, a novel technique 
of inducing tubulogenesis in endothelial cells was developed by using fibronectin and 
chitosan‟s hydrogel-like nanofibers‟ characteristics. This is a very important and 
translatable part of the research as the vascularization of biomaterial scaffolds can be 




3.2.1 Fibronectin Adsorption on Chitosan Films and Nanofiber 
In order to evaluate fibronectin adsorption on chitosan, 24-well tissue culture dishes were 
coated with 1% chitosan and dried for 1 hr before neutralization with 0.2 M ammonium 
hydroxide. Fibronectin (Sigma) solutions of different concentration (0 g/ml, 0.6 g/ml, 
1.2 g/ml, 5 g/ml, 10 g/ml, and 20 g/ml in deionized water) were added into the 
dishes and incubated for 1 hour. The chitosan nanofibers were treated with fibronectin 
solution (10 g/ml) for 1 hour at 37C and 10% CO2 incubator. The relative amount of 
adsorbed fibronectin was characterized by fluorescent staining intensity analysis using 
the primary rabbit anti-fibronectin (Sigma) and the secondary anti-rabbit IgG, alexa fluor 
488 (Invitrogen).  
3.2.2 Cell Seeding on Chitosan Film and Nanofibers 
Primary ventricular cardiomyocytes were isolated from 1-day-old neonatal Wistar rats 
(Charles River Laboratories, MA) using a collagenase procedure as described previously 
[106]. Briefly, the pups are anesthetized by spraying with ethanol and incubating in the 
refrigerator for 10 minutes. The beating heart is excised from a small abdominal incision. 
The hearts are washed with PBS and minced into small pieces. The minced heart pieces 
are then treated in 0.12% collagenase II solution in a series of digestion incubations each 
for 15 minutes and the dissociated cells are collected in 5% Horse serum. The harvested 
cells are then separated according to Percoll gradient. The cardiomyocyte layer is 
cultured on 0.1% gelatin coated dishes.    
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Cardiomyocyte culture medium consists of DMEM (Gibco, Gaithersburgh, MD) 
with 10% FBS (Biowest, Miami, FL), 2 mM L-glutamine (Gibco), 
insulin/transferrin/selenious acid (ITS; 5 g/mL, 5 g/mL, 5 ng/mL, respectively) 
(Invitrogen), and 2% penicillin/streptomycin (Gibco). Murine 3T3-J2 fibroblasts 
(purchased from Howard Green, Harvard Medical School, Boston, MA), were maintained 
in 60-mm tissue culture dishes in DMEM plus 10% FBS and 2% penicillin and 
streptomycin. Rat heart microvascular endothelial cells (MVEC; purchased from VEC 
Technologies, Rensselaer, NY) and rat liver sinusoidal endothelial cells (LSEC; isolated 
from adult rat liver), were maintained in DMEM supplemented with 10% FBS, 2 mM L-
glutamine, ITS, 2% penicillin/streptomycin, and 10 ng/mL vascular endothelial growth 
factor (VEGF, R & D Systems, Minneapolis, MN). Culture medium was changed every 
three days.  
For the 2-D cell cultures, the chitosan or chitosan/Fibronectin adsorbed films were 
prepared in 24-well tissue culture dishes, as described in Section 2.2. Cells were seeded 
at a density of ~25,000 cells/cm
2
 on the films in 0.5 mL of culture medium. For 3-D cell 
cultures, the nanofibers were treated with fibronectin solution (10 g/ml) for 1 hour to 
adsorb fibronectin on the fibers. The nanofibers were then soaked in culture medium for 
about 5 minutes prior to cell seeding. The suspended cells (fibroblasts, cardiomyocytes, 
or endothelial cells) in culture medium were directly seeded at a density of ~300,000 
cells/cm
2
 on separate chitosan nanofibrous mats with 300 l of medium and incubated for 
about 1 hour before adding further medium to allow for better cell entrapment and 
attachment. The mats were incubated in a 10% CO2, 37 
o
C incubator and the medium was 
changed every 3 days.  
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3.2.3 Tube Formation on Different Types of Gels 
Endothelial cell tube formation was tested on two different gel substrates:  collagen gel 
and Matrigel 
TM
. 0.1% (w/v) gelatin was prepared in deionized water. The gelatin 
solution was warmed in a 37°C water bath before use. Collagen gel (BD Biosciences) 
was prepared by mixing 1.2 mg/ml collagen solution with 10X DMEM at 9:1 ratio (v/v) 
at ice temperature and keeping it on ice until use. The Matrigel solutions (BD 
Biosciences) were maintained at ice temperature until use.   
150µL of each gel type substrate was added into a well of a 24-well plate and the 
gels were incubated at 37°C and 10% CO2 for 45 minutes to allow for gelation. The EC 
cells were cultured in endothelial cell medium, containing DMEM supplemented with 
10% Fetal Bovine Serum, 2% Penicillin/Streptomycin, 10g/ml Vascular Endothelial 
Growth Factor (VEGF) and 1X Insulin-Transferrin-Selenium (ITS). The cells were 
cultured at 37°C and 10% CO2 in p60 tissue culture dishes and harvested at 75-90% 
confluency. 
For harvesting cells, the p60 tissue culture dishes were washed twice with 3mL of 
Phosphate Buffer Solution (PBS) and then incubated with 1mL 1X trypsin (SAFC 
Biosciences, cat # 59428C-500ml) at 37°C and 10% CO2 incubator for 10 minutes. The 
cells detached from the surface of the tissue culture dish after the incubation period. With 
the help of a pipette, the surface of the tissue culture dish was further washed with the 
trypsin-cell suspension to ensure the detachment of any remaining attached cells. In 
addition, the trypsin-cell suspension was gently mixed with a pipette to cause the 
disintegration of any cells that might have detached as clusters. The trypsin was then 
neutralized by the addition of 5mL of the endothelial cell media and centrifuged at room 
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temperature for 10 minutes at a speed for 850 revolutions per minute. The supernatant 
was discarded and the cell pellet was re-suspended in 1mL of endothelial cell media.  
The cells were counted using a hemocytometer and seeded on top of the gel 
substrates at a density of 10,000 cells/cm
2
. The total volume of endothelial cell media 
added to the wells was 250µL. Tube formation was checked using light microscopy every 
24 hours of culture. Tube formation was classified as the alignment of the endothelial 
cells behind each other in a train-like fashion and the physical transformation of the cells 
into elongated or tubular morphologies. Light phase images were captured using Nikon 
camera (model number 150365). The media was changed every three days. 
3.2.4 Tube Formation on Chitosan Nanofibers 
The chitosan nanofibers were prepared into squares (20x20x0.15 mm
3
) and neutralized in 
a basic solution composed of 15N ammounium hydroxide and 100% ethanol (1:1 v/v) for 
30 minutes. The nanofibers were then washed with deionized water three times, each 
time for 10 minutes. The fibers were then incubated for 1 hour in 10µg/ml human 
fibronectin solution (BD Biosciences). The fibers were washed with endothelial cell 
media prior to cell seeding. Endothelial cells were seeded at a density of 200,000 
cells/cm
2
 directly on the fibronectin-coated chitosan nanofibers.  
3.2.5 Cell Attachment and Spreading Evaluation 
The samples were washed with PBS and fixed with 4% paraformaldehyde for 20 minutes 
at room temperature. After washing with PBS, the samples were permeabilized in 0.2% 
Triton X-100 in PBS for 10 minutes. The samples were then washed with PBS and 
incubated in blocking buffer (PBS/10% FBS/1% BSA) for 30 minutes. The primary 
antibody was then added and incubated for 60 minutes at room temperature. The samples 
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were washed with PBS and then incubated with the secondary antibody for 60 minutes. 
The samples were then washed and examined with fluorescence microscopy (Nikon). The 
primary antibodies used were mouse anti-vinculin (Millipore, 1:200 dilution), mouse 
anti- -sarcomeric actin (Invitrogen, 1:50 dilution), and rabbit anti-connexin 43 (Sigma, 
1:1000 dilution). The secondary antibodies used were donkey anti-mouse IgG, alexa fluor 
488 and donkey anti-rabbit IgG, alexa fluor 594 (Invitrogen).  
For the distribution of actin microfilaments, cells were stained by incubating fixed 
and permeabilized cultures with 0.1 g/mL rhodamine phalloidin (Sigma) for 30 min. In 
some cases, cells were counterstained with 4, 6-diamidino-2-phenylindole (DAPI; 
Invitrogen) for nuclear staining. In order to verify the adsorption of fibronectin onto 
chitosan, the samples were stained for 1 hr at room temperature with rabbit anti-
fibronectin. After washing twice with PBS, the samples were incubated with alexa fluor 
488 conjugated anti-rabbit IgG, and washed twice with PBS. Cell viability on the 
nanofiber scaffolds was examined by a live/dead viability/cytotoxicity kit (Invitrogen).   
3.2.6 Scanning Electron Microscopy (SEM) 
The cell seeded nanofibers scaffolds were examined with SEM. The samples were fixed 
with 2.5% gluteraldehyde for 24 hours at 4 
o
C. The samples were then washed with PBS 
and serially dehydrated with 50%, 70%, and 100% ethanol for 15 minutes each. This was 
done to allow gradual dehydration of the cells preventing loss of cellular structural 
integrity. The samples were then vacuum-dried for about 6 hours. The samples were 






3.2.7 Live/Dead Cell Staining 
Calcein AM/Ehidium homodimer live/dead cell stain was used to visualize the cells on 
the 2-D gel substrates and 3-D chitosan nanofibers. To stain the cells, the cell culture 
media was changed and Calcein AM and Ehtidium homodimer (Invitrogen L3224) were 
added at 1µL/ml of media to the cultures. The cultures were then placed at 37°C and 10% 
CO2 for 10 minutes prior to capturing images using the fluorescent microscope. Nuclear 
DAPI stain was also used to stain the nuclei of the cells by adding 1µL /ml of culture and 
incubated for 10 minutes.  
3.2.8 Safranin-O Staining 
Safaranin-O was used to stain the sulfated glucosaminoglycans present in the chitosan 
mats. The cell seeded mats were treated with 4% paraformaldehyde (Electron 
Microscopy Sciences, 15715-S) for 20 minutes.  2mL of the Safranin-O dye was then 
added to the culture dishes and incubated at room temperature for 10 minutes. The 
chitosan mats were then washed with water at least three times. Light images were then 












3.3.1  Fibronectin Adsorption on the Chitosan Scaffolds 
It is known that cellular attachment to biomaterials is enhanced by immobilizing 
fibronectin by adsorption. To establish the concentration at which chitosan is saturated by 
fibronectin adsorption, immunofluorescent staining of adsorbed fibronectin using varying 
concentrations (0 g/ml to 20 g/ml) was performed. Figure 3.1 illustrates an increase in 
observed fluorescence intensity with fibronectin concentration, which suggests that 
fibronectin adsorption on chitosan coated wells is dependent on the concentration of the 
fibronectin solution. There was a steady increase in the amount of adsorbed fibronectin as 
the concentration increases and the adsorption plateaus beyond 10 g/ml. As a result, the 
10 g/ml solution was used to adsorb fibronectin on the chitosan nanofibers for improved 
cell adhesion.  
 
Figure 3.1 Fibronectin adsorption on chitosan. (A) Relative fluorescence intensity of 
adsorbed fibronectin on chitosan coated tissue culture dishes at various fibronectin 
concentrations by immunofluorescence staining. (B and C) Light phase and 
immunofluorescence staining for anti-fibronectin of chitosan nanofibers adsorbed by 






3.3.2  Effect of Fibronectin on Cellular Morphology and Cytoskeletal Organization 
In order to investigate the effect of fibronectin immobilization on chitosan material in cell 
cultures, the morphology and cytoskeletal protein distribution of endothelial cells and 
cardiomyocytes were monitored on 2-D chitosan films with and without fibronectin 
adsorption. The optical microscopy and fluorescent staining in Figure 3.2A (endothelial 
cells) and 3.2C (cardiomyocytes) indicates that the cells maintain a rounded morphology, 
minimal vinculin (focal adhesion) expression, and a diffused F-actin cytoskeletal 
organization when cultured on chitosan film. In contrast, the cells cultured on fibronectin 
coated chitosan films demonstrated enhanced cellular spreading, significant increase in 





Figure 3.2 Morphology, Vinculin (focal adhesion) expression, and cytoskeletal F-actin 
organization of (A and B) endothelial cells (EC) and (C and D) cardiomyocytes cultured 
on chitosan and chitosan-fibronectin coated tissue cultured dishes (day 2 cultures). Light 
phase contrast and immunoflourescence staining images for Vinculin (green), 
cytoskeletal F-actin (red), and nuclear DAPI (blue) of endothelial cells and 
cardiomyocytes . 200X original magnification.  
 
Similarly, the endothelial cells seeded on non-coated chitosan nanofibers retained 
their circular morphology and did not attach to the nanofibers. Figure 3.3 depicts SEM 
micrographs of the endothelial cells seeded on coated and non-coated chitosan nanofibers. 
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It is clear that the cells extend pseudo pods and attach onto the nanofibers when they are 
coated with fibronectin.  
 
Figure 3.3 (A and B) SEM micrographs of non-coated and fibronectin coated chitosan 
nanofibers seeded with endothelial cells (MVEC) after 1 day culture. 5,000X original 
magnification. (C and D) Live cell calcein AM stained endothelial cells cultured on non-
coated and fibronectin coated chitosan nanofibers after 1 day culture. 200X original 
magnification.  
 
3.3.3  Characterization of Cellular Behavior in Chitosan Nanofibrous Mats 
Assessment of cellular viability and morphology was performed to evaluate the 
cytocompatibility of electrospun chitosan nanofibrous mats and their potential as cellular 
scaffolds. Three day culture of fibroblasts on the chitosan nanofibers demonstrated 
endothelial cells, and cardiomyocytes were seeded onto fibronectin coated chitosan mats 







cultured on the chitosan nanofiber scaffolds, indicating the chitosan nanofibers do not 
adversely affect cell viability. Some cells formed filopodia-like extensions to attach to the 
fibers, assisting them in spreading inside the chitosan nanofibrous scaffold, Figure 3.5 A. 
In addition, the SEM images exhibit the formation of a film-like material surrounding the 
densely seeded areas, indicating the secretion and immobilization of cell secreted ECM 
components. 
 
Figure 3.4 (A) Live cell calcein AM staining (B) Dead cell Ethidium homodimer staining 
and (C) Light phase image of 3T3-J2 fibroblasts cultured on chitosan-fibronectin 
adsorbed nanfoibers for 4 days. 200X original magnification. (D-F) SEM images of 
fibroblasts, cardiomyocytes, and endothelial cells cultured on chitosan-fibronectin 







Figure 3.5 (A) SEM micrograph of fibroblasts cells after 9 day culture in chitosan 
nanofibers showing the extension of pseudopods to attach to physically attach to the 
fibers, 5000X original magnification. (B)  SEM micrograph of fibrous extracellular 
matrix extruding from the cell surface to the chitosan nanofibers, 40 000X original 
magnification. (C) Immunofluorescent staining of cytoskeletal f-actin (red) and nuclear 
DAPI (blue) to illustrate fibroblasts day 9 cellular distribution within the nanofibers, 
100X original magnification. 
 
3.3.4  Effect of Gel Type and Cell Density on Tube Formation from Endothelial 
Cells. 
Endothelial cells (LSEC) cultured on Collagen gel did not results in any tube formation at 
either cell densities as seen in Figure 3.6. However, when LSEC were cultured on 
Matrigel, the low density culture (50,000 cells/cm
2
) resulted in disconnected tubes as 














                   
Figure 3.6 Light phase images of LSEC cultured on collagen gel and Matrigel at low and 
high cell densities. (A) collagen at 50 k cells/cm
2
 (B) Matrigel at 50 k cells/cm
2
 (C) 
collagen at 125 k cells/cm
2
 (D) Matrigel at 125 k cells/cm
2
. All images were captured 
after 24 hours of incubation at 37°C and 10% CO2. 40X original magnification. 
 
LSEC cultured on chitosan nanofibers were observed to form interconnected 
networks over three weeks of culture periods. Capillary-like network formations 
increased over time and they remained structurally stable and viable up to 21 days as seen 
in Figures 3.7 A-D. 
 








Figure 3.7 Calcein AM live cell staining of LSEC cultures in chitosan nanofiber mats 
(A) day 1 (B) day 7 (C) day 14 and (D) day 21. 40X original magnification. 
 
  It is evident from Figures 3.7 and 3.8 that the endothelial cells seeded on the 
fibronectin coated chitosan nanofibers were able to migrate and develop intercellular 








      
     
 
Figure 3.8 LSEC tube-like network structures in the chitosan nanofibers 80 k cells/cm
2
 
on day 14 (A) Calcein AM live cell stained image, 200X (B) Scanning electron 
micrograph, 10,000X and (C) Safranin-O stained image of cell seeded scaffold (D) 




3.4  Discussion 
The goal of this section of the research was to improve the cytocompatibility of chitosan 
using fibronectin adsorption and induce tubulogenesis of endothelial cells.  
Fibronectin adsorption on chitosan improved cellular attachment significantly. 
This was possible because of chitosan‟s cationic nature which does not cause the loss of 
the biological activity of the adsorbed fibronectin. Proteins not do denature when 
adsorbed on hydrophilic surfaces such as cationic chitosan as their confirmation is not 
altered significantly [107]. Hence the fibronectin was adsorbed on the chitosan films 





attachment was successfully accomplished on the chitosan nanofibers as well. It is clear 
that the fibronectin adsorbed chitosan nanofibers induce the cells to form pseudopods and 
attach to the nanofibers. Furthermore, the cells seeded on the nanofibers began to migrate 
through the inter-fiber voids, secrete their own extra cellular matrix and form a coherent 
3-dimensional tissue-like network. This migration of cells through the scaffold was 
clearly demonstrated using tubulogenesis which is the intercellular alignment of cells to 
form interconnected tubes. 
Vascular morphogenesis, among other complex cellular processes, is orchestrated 
via interaction between the cell's genetic information and the interstitial extracellular 
matrix (ECM). The ECM functions as a dynamic scaffold providing malleable biological 
and physical cues that coordinate the cells‟ fate. In this study, first we investigated the 
effect of two different gel substrates and cell seeding densities on one of the stages of 
vascular morphogenesis: intercellular alignment into tubes. In addition, 3-dimensional 
tube formation was studied on fibronectin adsorbed chitosan nanofibers.  
Collagen gel and Matrigel were the two gel substrates investigated. Gelatin is 
derived from denatured natural collagen.  Collagen is the fibrous structural protein 
component of the natural in vivo ECM. Matrigel is the reconstituted soluble basement 
membrane extract derived from the Engelbreth-Holm-Swarm (EHS) sarcoma. This 
laminin-rich basement membrane gelatinous substrate contains other ECM components 
such as collagen IV, heparin sulfate proteoglycan, entactin/nidogen, and growth factors 
[108].  
As seen in Figure 3.6, LSEC resulted in intercellular alignment only when they 
were cultured on Matrigel. These results might be caused by differences in the biological 
56 
 
nature of cellular attachment to the gel substrates. Matrigel is rich in laminin which 
induces endothelial cell alignment and capillary tube formation by interacting with the 
cell using the YIGSR sequence in the B1 chain and RGD sequence in the A chain [109].  
Furthermore, it has been reported that cellular traction on the Matrigel surface generates 
narrow tracks on the gel surface along which the endothelial cells can migrate to align 
themselves into tubes [110].  
Interconnected tubular formation was evident when the cell seeding density was 




 on 100% Matrigel as evident in Figure 
3.6. The endothelial cells‟ morphogenesis into the vascular phenotype requires the 
coordination of multiple behaviors including migration, proliferation, intercellular 
alignment and adhesion and the generation of a lumen [111]. Endothelial cells‟ behavior, 
survival and proliferation is heavily dependent on the integrin mediated interactions with 
basement membrane components within the Matrigel [112].   
In addition, tube formation was investigated on the chitosan nanofibers without 
the use of Matrigel. Figure 3.7 clearly demonstrates that LSECs have migrated across the 
nanofibers and have aligned themselves linearly to form interconnected network tubes. 
The intercellular alignment of LSEC on the nanofibers could be the result of physical 
cues from the architecture of the nanofibers. As the endothelial cells attach and migrate 
across the chitosan nanofibers they can cause traction by pulling on the nanofibers and 
communicate mechanically with neighboring cells about their spatial organization. The 
cells can sense the mechanical signals through their transmembrane ECM receptors such 
as focal contact sites [113]. The phosphorylation of integrin by protein kinases at these 
focal contact sites can induce cytoskeletal reorganization which might mediate tubular 
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morphogenesis [114]. Hence, mechanochemical cues caused by the cells traction on the 
nanofibers trigger morphogenic signaling that mediates tube formation.  
Nevertheless, the influence on the morphogenesis of endothelial cells by the 
substrate‟s architecture is one of the factors amongst an elusive matrix of factors that 
synchronize vascular morphogenesis. To our knowledge this is the first report of 
endothelial tube formation on 3-dimensional chitosan nanofibers without the use of the 
most commonly used angiogenic gel substrates such as Laminin and Matrigel. 
 
3.5  Conclusion 
The biological performance of the chitosan nanofibers was successfully improved via 
fibronectin adsorption. The migration of endothelial cells and intercellular alignment into 
tubes in the chitosan nanofibers exhibits the immense potential of using chitosan 
nanofibers as vascularized tissue engineered constructs or in vitro tissue models. In the 
next section, the vascularized chitosan nanofibers will be impregnated with a 












VASCULARIZED CARDIOMYOCYTE/FIBROBLAST CO-CULUTRE MODEL  
 
4.1  Introduction 
In the adult human myocardium, cardiomyocytes compose about 70% of myocardial 
tissue volume but only 30% of the cell population [115].  The remaining cell population 
is mainly composed of fibroblasts, followed by endothelial cells, smooth muscle cells, 
pericytes, macrophages, and nerve cells [116-118]. The mentioned cell species are 
organized in a very unique 3-dimensional architecture that optimizes mechanical and 
electrical coupling enabling the myocardial tissue to sustain its contractile function. The 
extracellular matrix (ECM) provides a scaffold in which all the cells are spatially 
coordinated, as seen in Figure 4.1.  
 
Figure 4.1 Graphical representation of the cardiomyocyte tubules in the native 
myocardium [119].  
 
Some of the principal challenges of generating a thick functional myocardial 
construct are maintaining in vitro cardiomyocyte function and structure, recreating the 
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intricate physical and chemical myocardial milieu, and vascularizing the dense construct. 
In the past section, we were successful in vascularizing the chitosan scaffold with 
endothelial cells. Hence, in this section, our aim is to impregnate the vascularized 
chitosan scaffold with cardiomyocytes and fibroblasts to get closer to the in vitro 
recreation of the cardiac cellular mosaic that can function as a myocardial tissue model. 
Each cell in this cardiac mosaic performs vital functions that enable the optimum 
functionality of the cardiomyocytes. For instance, as seen in Figure 4.2, each cell within 
the myocardium is involved in the secretion of certain extracellular components 
dependant on the mechanical and neurohormonal cues received by them. 
 
Figure 4.2 Graphical representation of the diverse cellular milieu of the myocardium. 
The cells have unique and overlapping contributions to the myocardium extracellular 
constituents [120]. 
 
The cardiac fibroblasts produce the heart's interstitial ECM fibrillar proteins 
which are predominantly Type I and III collagens and elastin [121]. The fibrous collagen 
network maintains the structural integrity of the heart tissue as the cardiomyocytes 
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shorten and the entire tissue contracts [122]. Fibroblasts have also been shown to assist in 
electrical propagation of the wavefront [123]. Each cardiomyocyte is surrounded by 
multiple fibroblasts, this close relation is vital for the mechanical and biochemical 
communication between the two cell types. For instance, the secretion of stretch-induced 
growth factors from cardiomyocytes activate fibroblasts cell proliferation and collagen 
synthesis to counteract stress increases [124].   
 
Figure 4.3 Diagrammatic representation of the connexin 43/45 gap junctions between 
fibroblasts and cardiomyocytes that regulate the syncytial network within the 
myocardium [125].  
 
Cardiomyocytes form distinct layers that wrap around the contour of the heart. 
Each cardiomyocyte is about 10-15um in diameter, 100um in length, and are connected 
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end-to-end in both the longitudinal and transverse directions [117]. The maturation, 
survival and function of cardiomyocytes are dependent on various physiological cues 
including the physical and mechanical ECM cues which are relayed through the collagen-
integrin-cytoskeletal relation [117]. Endothelial cells populate the complex vasculature 
networks that perfuse the myocardial tissue. However, endothelial cells functions are not 
confined to forming the capillary beds but they also affect cardiomyocyte survival, 
contraction rhythmicity and cardiomyocyte organization via paracrine signaling.  
 
Figure 4.4 Graphical representation of the paracrine and autocrine signaling that 
constitute endothelial-cardiomyocyte interactions [96]. 
 
Simulating the in vivo myocardial cellular architecture with fibroblasts and 
endothelial cells will present the cardiomyocytes with a physiological milieu that is closer 
to the native environment and hence assist in retaining their function [126, 127]. The 
intercellular interactions via gap junctions, cell-cell adhesion proteins and paracrine 
signaling will aid in recreating the in vivo cellular communication that is vital in 
maintaining optimum cardiomyocyte function and survival [128-130]. The 3-D 
nanofibers will provide a physical matrix with interconnected spaces similar to the 
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collagenous fibers in the native extracellular matrix. The pre-vascularization of the 
construct will serve as an in vitro perfusion system to supply essential nutrients and 
oxygen to the core of the scaffold. In addition, the 3-D vasculature will enable 
endothelial-cardiomyocyte intercellular communication that affect electrical 
synchronization and contraction rhythmicity [126]. The pre-vascularization of the 
construct might also help host vasculature to integrate faster into the construct as the 
construct is already vascularized. 
The main objective of this part of the research is to use the fibronectin 
functionalized and vascularized chitosan nanofibers to create a tri-culture cardiomyocyte-
fibroblast-endothelial in vitro cardiac tissue model.  
 
4.2  Methods 
4.2.1  Cardiomyocyte Mono- and Co-cultures on Chitosan Films and Nanofibers 
For the co-culture studies (cardiomyocytes-fibroblasts or cardiomyocytes-endothelial 
cells co-culture) in 2-D and 3-D culture systems, cells were seeded at the ratio of 1 to 1, 
giving a total initial cell number (cardiomyocytes+fibroblasts or 
cardiomyocytes+endothelial cells) of ~50,000 cells/cm
2
 for 2-D and ~600,000 cells/cm
2 
for 3-D cultures. (For detailed methodology in terms of chitosan film and nanofiber 
handling and cell seeding please refer to section 3.2) 
4.2.2  Vascularized Cardiomyocyte-Fibroblasts Co-culture on Chitosan Nanofibers: 
The chitosan nanofibers were neutralized, sterilized and incubation in fibronectin as 
mentioned in Section 2.4. LSEC cells were seeded on the chitosan nanofibers at a density 
of 125,000 cells/cm
2
 and cultured for 7 days to allow for tube formation. Cardiomyocytes 
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and fibroblasts were seeded at a density of 125,000 cells/cm
2
 each and cultured for an 
additional 7 days.  
4.2.3  Immunohistochemsitry of Sarcomeric Actin and Connexin-43: 
The samples were washed with PBS and fixed with 4% paraformaldehyde for 20 minutes 
at room temperature. After washing with PBS, the samples were permeabilized in 0.2% 
Triton X-100 in PBS for 10 minutes. The samples were then washed with PBS and 
incubated in blocking buffer (PBS/10% FBS/1% BSA) for 30 minutes. The primary 
antibody was then added and incubated for 60 minutes at room temperature. The samples 
were washed with PBS and then incubated with the secondary antibody for 60 minutes. 
The samples were then washed and examined with fluorescence microscopy (Nikon). The 
primary antibodies used were mouse anti-vinculin (Millipore, 1:200 dilution), mouse 
anti- -sarcomeric actin (Invitrogen, 1:50 dilution), and rabbit anti-connexin 43 (Sigma, 
1:1000 dilution). The secondary antibodies used were donkey anti-mouse IgG, alexa fluor 
488 and donkey anti-rabbit IgG, alexa fluor 594 (Invitrogen). 
4.2.4  Calcium Transient Ion Staining: 
Calcium indicator, fluo-4 AM (Invitrogen, F-14201) was reconstituted in sterile DMSO 
to make a stock concentration of 2mM. Using cardiomyocyte media, the stock was 
diluted to a final working concentration of 4µM. The cells were incubated in the 4µM 
indicator media for 45 minutes at 37 
o
C. The cells were then washed with only 
cardiomyocyte medium twice before incubating in cardiomyocyte medium for another 30 
minutes at 37C. The indicator dye was excited using a 488nm laser. Videos of the 
Calcium ion staining were captured using Nikon NIS-Elements Basic research_advanced. 
Pseudocolor images of the Calcium ion fluorescence intensity were captured every 
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150ms. The intensity of the calcium ion flux was determined by taking the average 
intensity from 12 pixel image points from each frame and plotting the average intensity 
over time. 
4.3 Results 
4.3.1  Co-culture Effect on Cardiomyocytes’ Morphology and Gap Junctions  
Cardiomyocyte morphology and gap junction formation were monitored via sarcomeric 
alpha-actin (SA-actin) and connexin-43 (Cx43) staining, respectively.  Cardiomyocytes‟ 
SA-actin and Cx43 expression was examined on both fibronectin adsorbed chitosan films 
(2-D) and fibronectin adsorbed chitosan nanofibers (3-D). In each condition, 
cardiomyocytes were cultured in monocultures (cardiomyocytes only) and co-cultures 
(cardiomyocytes-fibroblasts or cardiomyocytes-endothelial cells). 
 
Figure 4.5 Morpholoy and phenotypic characteristics of primary neonatal 
cardiomyocytes cultured on 2-dimensional Chitosan-fibronectin films. (A,D) 
Cardiomyocyte monoculture, (B, E) Cardiomyocytes co-culture with fibroblasts, and (C, 
F) cardiomyocytes with endothelial cells after 7 days incubation at 37°C and 10% CO2. 
Cardiomyocytes were immunostained for α-sarcomeric actin (SA) and connecin-43 
(Cx43) gap junction expression. 200X original magnification 
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In the 2-D systems, the cardiomyocyte monoculture (Figure 4.5 A, D) exhibited 
low expression of SA-actin and the cardiomyocytes lost their structural polarity and 
acquired a rounded morphology. Gap junction protein Cx43 expression was minimal in 
the monoculture system, resulting in isolated islands of contractions. In the fibroblasts co-
culture system (Figure 4.5 B, E), the cardiomyocytes maintained a highly polar 
morphology and the SA-actin was strongly expressed along the axis of morphological 
polarity. In addition, Cx43 expression was the highest in the fibroblasts co-culture which 
enabled the cardiomyocytes to contract in a tissue-like synchronized manner. The 
cardiomyocytes co-cultured with endothelial cells (Figure 4.5 C, F) demonstrated a 
spherical morphology with lower levels of SA-actin and Cx43 expression than those in 
the fibroblasts co-culture as well as isolated contractions. 
To assess the chitosan nanofibers‟ potential as a cardiac tissue engineering 
scaffold, the same cardiomyocyte monoculture and co-culture studies were performed on 
the 3-D chitosan nanofibers. The cardiomyocyte monoculture (Figure 4.6 A, D) and 
cardiomyocytes-endothelial cell co-culture (Figure 4.6 C, F) did not have any visible SA-
actin or Cx43 expression. The cardiomyocyte-fibroblast co-culture resulted in elongated 
networks of contracting cardiomyocytes with the highest expression of SA-actin and 




Figure 4.6 Morpholoy and phenotypic characteristics of primary neonatal 
cardiomyocytes cultured in 3-dimensional chitosan electrospun nanofibrous matrices. 
(A,D) Cardiomyocyte monoculture, (B, E) Cardiomyocytes co-culture with fibroblasts, 
and (C, F) cardiomyocytes with endothelial cells after 19 days incubation at 37°C and 
10% CO2. Cardiomyocytes were immunostained for α-sarcomeric actin (SA) and 
connecin-43 (Cx43) gap junction expression. 200X original magnification 
 
In both 2-D and 3-D cultures on chitosan scaffolds, cardiomyocyte-fibroblasts co-
cultures resulted in polarized cardiomyocyte morphology with high levels of SA-actin 
and Cx43 expression over long-term culture periods. In addition, the fibroblasts co-
cultures demonstrated synchronized contractions involving large tissue-like cellular 
networks, indicating the maintenance of long-term and stable function of cardiomyocytes 
gap junctions. To our knowledge, the results of the present study provided the first 
evidence that 3-D chitosan nanofibers can be used as a potential scaffold that can retain 





4.3.2  Intracellular Calcium Ion Staining 
The intracellular calcium ion flux staining was used to assess cardiomyocyte viability and 
functionality. In the 2-D monoculture system, the cardiomyocyte lose their functionality 
and morphology within 5-6 days. Figure 4.7 shows the pseudo color time-frame images 
of the 2-D cardiomyocyte culture system.  The image analysis of the calcium flux 













Figure 4.7 Pseudo-color intensity time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 2D monoculture of neonatal primary 
cardiomyocytes cultured for 4 days. 200X original magnification  
 
 
Figure 4.8 Frequency of intracellular calcium ion flux in the 2D monoculture of neonatal  





Figure 4.9 shows the pseudo color time-frame images of the 2-D cardiomyocyte-
fibroblast co-culture system.  The image analysis of the calcium flux resulted in a 
frequency of 30 ± 4 contractions per minute.  
   
0 secs                             0.4 secs          0.8 secs 
 
   
1.2 secs      1.6 secs           2.0 secs 
Figure 4.9 Pseudo-color intensity time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 2D co-culture of neonatal primary cardiomyocytes 
and fibroblasts cultured for 4 days. 200X original magnification  
 
 
Figure 4.10 Frequency of intracellular calcium ion flux in the 2D co-culture of neonatal 
primary cardiomyocytes and fibroblasts after 4 days in culture. 
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Figure 4.11 shows the pseudo color time-frame images of the 3-D cardiomyocyte-
fibroblast co-culture system.  The image analysis of the calcium flux resulted in a 
frequency of 17 ± 3 contractions per minute.  
   
0 secs       0.7 secs          1.4 secs 
   
2.1 secs      2.8 secs          3.5 secs 
 
Figure 4.11 Pseudo-color intensity time frame images of intracellular calcium ion flux 
stained using fluo-4-AM indicator in 3D co-culture of neonatal primary cardiomyocytes 
and fibroblasts cultured for 7days. 200X original magnification  
 
 
Figure 4.12 Frequency of intracellular calcium ion flux in the 3D co-culture of neonatal 
primary cardiomyocytes and fibroblasts after 7 days in culture. 
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Figure 4.13 shows the pseudo color time-frame images of the 3-D triculture 
endothelial cell vascularized cardiomyocyte-fibroblast system.  The image analysis of the 
calcium flux resulted in a frequency of 28 ± 3 contractions per minute.  
 
Figure 4.13 Pseudo-color intensity time frame images of intracellular calcium ion flow in 
3D tri-culture system of endothelial cells, neonatal primary cardiomyocytes, and 
fibroblasts after 7 day culture, 200X original magnification 
 
 
Figure 4.14 Frequency of intracellular calcium ion flux in the 3D tri-culture of 
endothelial cells, neonatal primary cardiomyocytes, and fibroblasts after 7 days in culture. 
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From the pseudo-color image analysis it is important to observe the following: 
1. In the 2D cardiomyocyte-fibroblast coculture system, the cardiomyocytes attained 
an elongated morphology as compared to the mono-culture where the cells spread 
out and displayed a flattened morphology. 
2. In the 3D vascularized cardiomyocyte-fibroblast tri-culture system, the 
cardiomyocytes formed a network of tubules that displayed rhythmic and 




















Cardiac fibroblasts are the most abundant non-cardiomyocyte cells in the mature heart.  
Their functions include deposition of the extracellular matrix (ECM), paracrine signaling 
and propagation of the electrical stimuli. In this study, we used murine 3T3-J2 fibroblasts 
cell line for cardiac co-cultures because of their easy access, propagation, and high 
induction of epithelial cell functions (e.g. hepatocytes) [131-133]. The key feature of the 
approach used in this research is the co-culturing of cardiomyocytes with fibroblasts 
within a vascularized 3-D scaffold for long-term functionality of the cardiomyocytes. 
To investigate the functionality and viability of cardiomyocytes, the expression of 
contractile alpha-sarcomeric actin (SA) and cardiomyocyte gap junction protein 
connexin-43 (Cx43) was used. SA-actin expression is solely found in cardiomyocytes and 
is an indicative sign of cardiomyocyte functional maturity. Cx43 is the gap junction 
protein that is mainly found in ventricular cardiomyocytes [134]. The Cx43 mediates 
fibroblasts heterogeneous coupling, such as between cardiomyocytes and fibroblasts 
[135]. These gap junctions with fibroblasts are known to propagate electrical stimuli for 
100 m [134].  The results from both the 2-D and 3-D cultures indicate that fibroblasts 
co-cultures resulted in the highest levels of SA-actin and Cx43 expression, suggesting 
fibroblasts are essential in maintaining cardiomyocytes viability and function in vitro.  
The observed cardiomyocyte co-culture enhancement effect can be attributed to 
many of the fibroblasts‟ physiological functions in the native heart. Fibroblasts which 
constitute 70% of the normal adult heart regulate the mechanical stability and structural 
integrity of the cardiomyocytes via the dynamic generation of the extracellular matrix and 
its turnover. From a histological view point, the myocytes laminae are enclosed in a 
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network of endomysial collagen maintained by the fibroblasts [136].  Recent studies have 
observed that the extracellular matrix produced by the fibroblasts maintain Cx43 since it 
is regulated by heparin binding-epidermal growth factor (EGF) [137].  Hence, the results 
demonstrate that fibroblasts should be an integral part of any cardiac regenerative therapy 
as its role in providing a cardiomyocyte-compatible scaffold is of supreme importance. 
The tubulogenesis of the endothelial cells on the chitosan scaffold recreates the 
rich vasculature architecture that perfuses the native myocardial tissue. This technology 
can be used as a platform to induce vascularization of various tissue regeneration 
constructs or to build in vitro tissue models. The fact that cardiomyocytes are able to 
survive and contract on chitosan nanofibers mats has never been reported before, to our 
knowledge.  
To assess cardiomyocyte contractility, transient calcium ion staining was 
performed. Calcium is the most important ion involved in the excitation-contraction 
coupling in cardiomyocytes. Briefly, for contraction to occur, intracellular calcium ion 
concentration increases as calcium enters via depolarization-activated calcium 
transmembrane channels. This flux of calcium ions initiate the release of more calcium 
that is sequestered in the sarcoplasmic reticulum, Figure 4.15. The calcium binds to the 
thin-filamentous protein troponinC which cooperatively activates the myofilaments 
initiating contraction. For relaxation to occur, the intracellular calcium ions are depleted 
via SR Ca-ATPase, Na/Ca exchange, Ca ATPase and mitochondrial Ca uniport [138]. 
Hence, intracellular calcium ion is a great method to assess cardiomyocyte functionality 




Figure 4.15 The transport of calcium ions in ventricular myocytes. The inset graph 
depicts the time course of a cardiomyocyte action potential, Ca ion transient 
concentration and cardiomyocyte contraction in a rabbit ventricular myocyte at 37°C. 
NCX: Na/Ca exchange; ATP: ATPase; PLB: phospholamban; SR: sarcoplasmic 
reticulum (Image from Bers, 2002 [138]) 
 
The monoculture of cardiomyocytes on 2D lost their functionality and their 
polarized morphology after 4 days. This is evident by the slow bursts of transient calcium 
seen in the monocultures. The co-culture system with fibroblasts demonstrated how the 
fibroblasts induce elongated cardiomyocyte morphology and a more rhythmic and more 
frequent changes in intracellular calcium ion concentrations. The most important data set 
is the cardiomyocyte-fibroblasts co-culture in the vascularized chitosan nanofibrous 
scaffolds. It is clear that the cardiomyocytes have migrated and organized themselves into 
myocyte tubules. The calcium flux in these elongated cardiomyocyte tubules is 
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synchronized and have a periodicity that is established throughout the cardiomyocyte 
tubular networks. 
 
4.5  Conclusion 
Results of this section of the research demonstrate that chitosan nanofibers can be used as 
scaffolds for the development of 3-D cardiac tissue constructs. Primary neonatal 
cardiomyocytes lost their viability and functionality in vitro when cultured alone. The 
cardiac-fibroblasts co-culture model is a promising system for the maintenance of long-
term survival and functionality of cardiomyocytes in vitro. The fibroblast co-culture 
system also induces the cardiomyocytes to increase gap junction expression and attain 
tubular morphology. These modifications in the cardiomyocytes encourage the cells to 















SUMMARY AND FUTURE STUDIES 
 
The essence of this research endeavor was to create a cardiac tissue model. The avenue 
pursued to reach this goal focused on recreating, as close as possible, the acellular and 
cellular components of the cardiomyocyte in vivo cellular niche. The natural acellular 
components include but are not limited to the collagen nanofiber scaffold and the 
glycosaminoglycan hydrogel milieu. The natural cardiac cellular mosaic is mainly 
composed of the dense endothelial cell vasculature bed that perfuses a cardiomyocyte: 
fibroblast co-culture. In other words, the design inputs for the acellular and cellular 
components of the engineered cardiac tissue model were dictated by the natural cardiac 
tissue itself. 
 To satisfy the acellular design inputs, chitosan a cheap, non-toxic, biodegradable 
and naturally derived polysaccharide was electrospun into nanofibers to recreate the 
collagen nanofiber matrix. In addition, chitosan shares structural homology with the 
glycosaminoglycans of the natural extracellular matrix. Therefore, the electrospun 
chitosan nanofiber scaffold combined the physical collagenous nanofibrous architecture 
with the structural glycosaminoglycan functionality into one scaffold.  
 To recreate the myocardial cellular mosaic, the chitosan nanofibers were 
impregnated with endothelial cells and cultured for a week to allow the formation of a 
network of endothelial tubes resembling the myocardial vasculature bed. The mechanism 
of tubulogenesis induction by the fibronectin adsorbed chitosan nanofibers need further 
detailed characterization. The extracellular matrix plays a critical role in synchronizing 
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the signals that control angiogenesis. The literature provides evidence that suggests that 
the extracellular matrix balances vascular morphogenesis and vascular regression as 
shown in figure 5.1. Furthermore, integrin signal transduction pathways involving the 
activation of Cdc42 and Rac1 initiate critical downstream signaling molecules that 
control endothelial cell tube morphogenesis [139].  
 
 
Figure 5.1 The genes and signaling pathways that are involved in the regulation of 
vascular morphogenesis/regression balance. 
 
More specifically, there are a number of published results that point to the vital 
role of fibronectin receptors, α5β1, α4β1, and α9β1 in endothelial morphogenesis in the 
formation of blood vessels [140]. Knocking out fibronectin or the integrin α5 subunit 
results in substantial defects in the vascular phenotypes, pointing toward the essential role 
of the fibronectin-integrin ligand/receptor interaction in vascularization [141]. An 
interesting study to conduct would be the splicing of the fibronectin protein into smaller 
peptide sequences to determine which particular sequence is involved in the induction of 
vascular morphogenesis.  
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In addition to fibronectin, the induction of endothelial tubulogenesis and 
activation can be initiated via multiple extracellular matrix components such as different 
types of collagens and fibrin matrices which have been shown to increase the production 
of F-actin stress fibers and the disruption of VE-cadherin intercellular junction proteins 
resulting in endothelial morphogenesis into tubules. On the other hand as seen in figure 
5.2, laminin which is another component of the extracellular matrix does not induce the 
formation of stress fibers and VE-cadherin intercellular junctions remain intact [142].    
 
Figure 5.2 The effect of collagen type I, fibronectin,/fibrin, and lamini-1 on endothelial 
tubulogenesis. The activation of Src and Rho signaling pathways and suppression of Rac 
and PKA via collagen and fibronectin/fibrin interaction with α5β1 and αvβ3 integrin 
receptors leads to the formation of actin stress fibers, the dissociation of the intercellular 
junction proteins VE-cadherin and the tubular morphogenesis. However, laminin has the 
effect of stopping endothelial morphogenic events and the stabilization of the tubules via 
pericytes recruitment [142].  
 
The cardiomyocytes and fibroblasts were then seeded onto the vascularized 
chitosan scaffold to fully recapitulate the cellular composition of the myocardium. The 
results clearly show that the vascularized cardiomyocyte-fibroblasts system have induced 
the cardiomyocytes to communicate with each other to enable the formation of a network 
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of cardiomyocyte tubules that function in syncytium. This research demonstrates the 
importance of the fibroblasts co-culture in maintaining the functionality of primary 
cardiomyocytes in vitro for up to four weeks; a requirement for any useful cardiac tissue 
model. Furthermore, the endothelial tube formation on the chitosan nanofibers can be 
used as a platform technology to provide vasculature architecture for numerous tissue 
models.  
There are a number of studies that show evidence of the pro-inflammatory 
responses of chitosan as it attracts and activates macrophages. Feng et al. demonstrated 
that oligochitosan (less than 10 saccharide residues) can be internalized by macrophages 
via lectin receptors with mannose specificity [143]. Consequently, chitosan has a 
stimulatory effect on the secretion of tumor necrosis factor-α, interleukin-1 β, 
macrophage colony stimulating factor (GM-CSF), nitric oxide (NO), and interleukin-6 in 
macrophages [144]. Huang et al. attributes chitosan‟s inflammatory response to its 
cationic polyelectrolyte properties in attracting and activating macrophages [145]. This is 
due to the finding that cationic groups cause irreversible and strong cell adhesion 
invoking a strong inflammatory response [146]. These inflammatory responses can be 
controlled by varying the degree of deacetylation of the chitosan being used or by 
incorporating immune-modulating cells such as mesenchymal stem cells [147, 148].  
 The cardiac tissue model developed in this research showed promising results in 
terms of attaining cardiomyocyte tubular morphology, synchronized contractility, and a 
network of tubular endothelial cells. Future studies should focus on: 
1. Building a mechanical stimulation bioreactor to condition the cardiac tissue model 
with physiological loading. 
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2. Assessing the swelling and stability of the chitosan nanofibers in human plasma. 
3. Assessing the engraftment of the cardiac patch with in vivo animal studies. 
4. Studying the pharmacology of cardiac drugs on the cardiac patch to determine its 
feasibility as a diagnostics tool or drug screening tissue platform.  
5. Examining cross-sections of the tissue-model to assess the migration and 
infiltration of the cellular constructions within the scaffold. This can be done by 
cryogenic freezing of the tissue-model and then cross-sectioning them into pieces 
for histological staining. Another method would be the used of confocal 
microscopy to examine the vertical planes of tissue-model  
6. More detailed examination of the calcium ion staining to understand the cellular 
functioning and how it correlates with certain features or shoulders of the calcium 
ion wave. 
7. Study why the xenogeneic tissue model allows the cardiomyocyte to maintain 
functionality and viability.  
In conclusion, this research has shown “proof-of-concept” of maintaining primary 
cardiomyocyte viability and inducing tubular and tissue-like contractility via the 
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